NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
INTRODUCTION
PHINIA Inc. (together with its Consolidated Subsidiaries, the Company) is a Delaware corporation incorporated in 2023. PHINIA is a leader in the development, design and manufacture of integrated components and systems that are designed to optimize performance, increase efficiency and reduce emissions in combustion and hybrid propulsion for commercial vehicles and industrial applications (medium-duty and heavy-duty trucks, buses and other off-highway construction, marine, agricultural and industrial applications) and light vehicles (passenger cars, trucks, vans and sport-utility vehicles). The Company is a global supplier to most major original equipment manufacturers (OEMs) seeking to meet and exceed increasingly stringent global regulatory requirements and satisfy consumer demands for an enhanced user experience. Additionally, the Company offers a wide range of original equipment service (OES) solutions and remanufactured products as well as an expanded range of products for the independent (non-OEM) aftermarket.
Transition to Standalone Company
On December 6, 2022, BorgWarner Inc. (BorgWarner or Former Parent) announced plans for the complete legal and structural separation of its Fuel Systems and Aftermarket businesses by the spin-off of its wholly-owned subsidiary, PHINIA, which was formed on February 9, 2023 (the Spin-Off).
On July 3, 2023, BorgWarner completed the Spin-Off in a transaction intended to qualify as tax-free to the Company’s stockholders for U.S. federal income tax purposes, which was accomplished by the distribution of the outstanding common stock of PHINIA to holders of record of common stock of BorgWarner on a pro rata basis. Each holder of record of BorgWarner common stock received one share of PHINIA common stock for every five shares of BorgWarner common stock held on June 23, 2023, the record date. In lieu of fractional shares of PHINIA, BorgWarner stockholders received cash. As a result of these transactions, all of the assets, liabilities, and legal entities comprising BorgWarner’s Fuel Systems and Aftermarket businesses are now owned directly, or indirectly through its subsidiaries, by PHINIA. PHINIA is an independent public company trading under the symbol “PHIN” on the New York Stock Exchange.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The following paragraphs briefly describe the Company’s significant accounting policies.
Basis of presentation Prior to the Spin-Off on July 3, 2023, the historical financial statements of PHINIA were prepared on a stand-alone combined basis and were derived from BorgWarner’s consolidated financial statements and accounting records as if the Fuel Systems and Aftermarket businesses of BorgWarner had been part of PHINIA for all periods presented. Accordingly, for periods prior to July 3, 2023, our financial statements are presented on a combined basis and for the periods subsequent to July 3, 2023 are presented on a consolidated basis (all periods hereinafter are referred to as “consolidated financial statements”). The Company’s Consolidated Financial Statements were prepared in accordance with accounting principles in the United States of America (U.S. GAAP) pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). The balance sheet as of December 31, 2022 was derived from the audited financial statements as of that date.
Certain amounts for the prior periods presented were reclassified to conform to the current period presentation. Amounts that were previously presented as Due from BorgWarner, current and Due from BorgWarner, non-current are now presented within Receivables, net and Investments and long-term receivables, respectively. Amounts that were previously presented as Due to BorgWarner, current are now presented within Accounts payable and Other current liabilities. Amounts that were previously presented in Due to BorgWarner, non-current are now presented in Other non-current liabilities. The Company has also corrected for certain immaterial errors that impacted the consolidated balance sheet as of December 31, 2022.
Management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and accompanying notes, as well as amounts of revenues and expenses reported during the periods covered by those financial statements and accompanying notes. The Consolidated Financial Statements may not be indicative of the Company’s future performance and do not necessarily reflect what the financial position, results of operations, and cash flows would have been had it operated as a standalone company during the periods presented prior to the Spin-Off.
The Consolidated Statements of Operations include all revenues and costs directly attributable to the Company, including costs for facilities, functions, and services utilized. Costs for certain centralized functions and programs provided and administered by BorgWarner were charged directly to the Company prior to Spin-Off. These centralized functions and programs included, but were not limited to research and development and information technology.
A portion of BorgWarner’s total corporate expenses were allocated to the Company for services rendered by BorgWarner prior to the Spin-Off. These expenses included the cost of corporate functions and resources, including, but not limited to, executive management, finance, accounting, legal, human resources, research and development and sales. Additionally, a portion of the Company’s corporate expenses were allocated to BorgWarner for charges incurred related to subsidiaries of BorgWarner historically supported by the Company, primarily related to information technology. These expenses were allocated based on direct usage when identifiable or, when not directly identifiable, on the basis of proportional net revenues, legal entities, headcount or weighted-square footage, as applicable. The Company considers the basis on which the expenses have been allocated to reasonably reflect the utilization of services provided to, or the benefit received by, both the Company and BorgWarner during the periods presented. However, the allocations may not reflect the expenses the Company would have incurred if the Company had been a standalone company for the periods presented prior to July 3, 2023. The year ended December 31, 2023 included net corporate allocation expenses incurred prior to the Spin-Off totaling $89 million. For the years ended December 31, 2022 and 2021, net corporate allocation expenses totaled $118 million and $84 million, respectively. Corporate allocation expenses were primarily included in Selling, general and administrative expenses.
Use of estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the accompanying notes, as well as the amounts of revenues and expenses reported during the periods covered by these financial statements and accompanying notes. Actual results could differ from those estimates.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Principles of consolidation The Consolidated Financial Statements include all majority-owned subsidiaries with a controlling financial interest. All inter-company balances and transactions have been eliminated in consolidation.
Joint venture and equity securities The Company has an investment in one unconsolidated joint venture which was acquired as part of the acquisition of Delphi Technologies on October 1, 2020: Delphi-TVS Diesel Systems Ltd (D-TVS), of which the Company owns 52.5%. This joint venture is a non-controlled affiliate in which the Company exercises significant influence but does not have a controlling financial interest and, therefore, is accounted for under the equity method. Although the Company is the majority owner, it does not have the ability to control significant decisions or management of the entity. The Company evaluated this investment under Accounting Standards Codification (ASC) Topic 810 and based on the following factors the Company does not have the power to control the significant decisions of the entity and therefore does not have a controlling financial interest.
•Both partners appoint a managing director and these directors jointly manage all of the affairs of D-TVS, subject to supervision by the board of directors;
•The Company has only a 36% representation on the board of directors; and
•The construct of the board of directors prevents either party from having power/control as described in ASC Topic 810 because both parties lack the ability to directly and/or indirectly control governance and management of D-TVS through either its ownership interest or the board representation.
Generally, under the equity method, the Company’s original investment is recorded at cost and subsequently adjusted by the Company’s share of equity in income or losses. The carrying value of the Company’s investment was $48 million and $44 million as of December 31, 2023 and 2022, respectively. The Company monitors its equity method investments for indicators of other-than-temporary declines in fair value on an ongoing basis. If such a decline has occurred, an impairment charge is recorded, which is measured as the difference between the carrying value and the estimated fair value. The Company’s investment in this non-controlled affiliate is included within Investments and long-term receivables in the Consolidated Balance Sheets. The Company’s share of equity in income or losses is included in Equity in affiliates’ earnings, net of tax in the Consolidated Statements of Operations.
The Company also has certain investments for which it does not have the ability to exercise significant influence (generally when ownership interest is less than 20%). The Company’s investment in these equity securities is included within Investments and long-term receivables in the Consolidated Balance Sheet.
Interests in privately held companies that do not have readily determinable fair values are accounted for using the measurement alternative under ASC Topic 321, which includes monitoring on an ongoing basis for indicators of impairments or upward adjustments. These equity securities are measured at cost less impairments, adjusted for observable price changes in orderly transactions for the identical or similar investment of the same issuer. If the Company determines that an indicator of impairment or upward adjustment is present, an adjustment is recorded, which is measured as the difference between carrying value and estimated fair value. Estimated fair value is generally determined using an income approach on discounted cash flows or negotiated transaction values.
Revenue recognition Revenue is recognized when performance obligations under the terms of a contract are satisfied, which generally occurs with the transfer of control of the products. For most products, transfer of control occurs upon shipment or delivery; however, a limited number of customer arrangements for highly customized products with no alternative use provide the Company with the right to payment during the production process. As a result, for these limited arrangements, revenue is recognized as goods are produced and control transfers to the customer using the input cost-to-cost method. Revenue is measured at the amount of consideration the Company expects to receive in exchange for transferring the goods. Although the Company may enter into long-term supply arrangements with its major customers, the prices and volumes are not fixed over the life of the arrangements, and a contract does not exist for purposes of applying ASC Topic 606 until volumes are contractually known.
Sales incentives and allowances (including returns) are recognized as a reduction to revenue at the time of the related sale. The Company estimates the allowances based on an analysis of historical experience. Taxes assessed by a governmental authority collected by the Company concurrent with a specific revenue-producing transaction are excluded from net sales. Shipping and handling fees billed to customers are included in sales, while costs of
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
shipping and handling are included in cost of sales. The Company has elected to apply the accounting policy election available under ASC Topic 606 and accounts for shipping and handling activities as a fulfillment cost.
The Company has a limited number of arrangements with customers where the price paid by the customer is dependent on the volume of product purchased over the term of the arrangement. In other arrangements, the Company will provide a rebate to customers based on the volume of products purchased during the course of the arrangement. The Company estimates the volumes to be sold over the term of the arrangement and recognizes revenue based on the estimated amount of consideration to be received from these arrangements.
Refer to Note 2, “Revenue from Contracts with Customers,” to the Consolidated Financial Statements for more information.
Cost of sales The Company includes materials, direct labor and manufacturing overhead within cost of sales. Manufacturing overhead is comprised of indirect materials, indirect labor, factory operating costs, warranty costs and other such costs associated with manufacturing products for sale.
Cash and cash equivalents Cash and cash equivalents are valued at fair market value. It is the Company's policy to classify all highly liquid investments with original maturities of three months or less as cash and cash equivalents. Cash and cash equivalents are maintained with several financial institutions. Cash and cash equivalents are primarily held in foreign locations. Deposits held with banks may exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and are maintained with financial institutions of reputable credit and, therefore, bear minimal risk.
Receivables, net and long-term receivables Accounts receivable and long-term receivables are stated at cost less an allowance for credit losses. An allowance for credit losses is recorded for amounts that may become uncollectible in the future. The allowance for credit losses is an estimate based on expected losses, current economic and market conditions, and a review of the current status of each customer’s accounts receivable.
Sales of receivables are accounted for in accordance with the ASC Topic 860. Agreements which result in true sales of the transferred receivables, as defined in ASC Topic 860, which occur when receivables are transferred to a third party without recourse to the Company, are excluded from amounts reported in the Consolidated Balance Sheets. Cash proceeds received from such sales are included in operating cash flows. The expenses associated with receivables factoring are recorded in the Consolidated Statements of Operations within interest expense. Refer to Note 7, “Receivables, Net,” to the Consolidated Financial Statements for more information.
Inventories Inventory is measured using first-in, first-out (FIFO) or average-cost methods at the lower of cost or net realizable value. Refer to Note 8, “Inventories,” to the Consolidated Financial Statements for more information.
Pre-production costs related to long-term supply arrangements Engineering, research and development and other design and development costs for products sold on long-term supply arrangements are expensed as incurred unless the Company has a contractual guarantee for reimbursement from the customer. Costs for molds, dies and other tools used to make products sold on long-term supply arrangements for which the Company has title to the assets are capitalized in property, plant and equipment and amortized to cost of sales over the shorter of the term of the arrangement or over the estimated useful lives of the assets, typically three to five years. Costs for molds, dies and other tools used to make products sold on long-term supply arrangements for which the Company has a contractual guarantee for lump sum reimbursement from the customer are capitalized in Prepayments and other current assets.
Property, plant and equipment, net Property, plant and equipment is valued at cost less accumulated depreciation. Expenditures for maintenance, repairs and renewals of relatively minor items are generally charged to expense as incurred. Renewals of significant items are capitalized. Depreciation is generally computed on a straight-line basis over the estimated useful lives of the assets. Useful lives for buildings range from fifteen to forty years, and useful lives for machinery and equipment range from three to twelve years. For income tax purposes, accelerated methods of depreciation are generally used. Refer to Note 10, “Property, Plant and Equipment, Net,” to the Consolidated Financial Statements for more information.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Impairment of long-lived assets, including definite-lived intangible assets The Company reviews the carrying value of its long-lived assets, whether held for use or disposal, including other amortizable intangible assets, when events and circumstances warrant such a review under ASC Topic 360. In assessing long-lived assets for an impairment loss, assets are grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. In assessing long-lived assets for impairment, management generally considers individual facilities to be the lowest level for which identifiable cash flows are largely independent. A recoverability review is performed using the undiscounted cash flows if there is a triggering event. If the undiscounted cash flow test for recoverability identifies a possible impairment, management will perform a fair value analysis. Management determines fair value under ASC Topic 820 using the appropriate valuation technique of market, income or cost approach. If the carrying value of a long-lived asset is considered impaired, an impairment charge is recorded for the amount by which the carrying value of the long-lived asset exceeds its fair value.
Management believes that the estimates of future cash flows and fair value assumptions are reasonable; however, changes in assumptions underlying these estimates could affect the valuations. Significant judgments and estimates used by management when evaluating long-lived assets for impairment include (1) an assessment as to whether an adverse event or circumstance has triggered the need for an impairment review; (2) undiscounted future cash flows generated by the asset; and (3) fair valuation of the asset.
Goodwill and other intangible assets During the fourth quarter of each year, the Company qualitatively assesses its goodwill. This qualitative assessment evaluates various events and circumstances, such as macroeconomic conditions, industry and market conditions, cost factors, relevant events and financial trends, that may impact a reporting unit's fair value. Using this qualitative assessment, the Company determines whether it is more-likely-than-not the reporting unit's fair value exceeds its carrying value. If it is determined that it is not more-likely-than-not the reporting unit's fair value exceeds the carrying value, or upon consideration of other factors, including recent acquisition, restructuring or disposal activity or to refresh the fair values, the Company performs a quantitative goodwill impairment analysis. In addition, the Company may test goodwill in between annual test dates if an event occurs or circumstances change that could more-likely-than-not reduce the fair value of a reporting unit below its carrying value.
The Company has definite-lived intangible assets related to developed technology and customer relationships. The Company amortizes definite-lived intangible assets over their estimated useful lives. The Company also has intangible assets related to acquired trade names that are classified as indefinite lived when there are no foreseeable limits on the periods of time over which they are expected to contribute cash flows. Costs to renew or extend the term of acquired intangible assets are recognized as expense as incurred.
Similar to goodwill, the Company can elect to perform the impairment test for indefinite-lived intangibles other than goodwill (trade names) using a qualitative analysis, considering similar factors as outlined in the goodwill discussion in order to determine if it is more-likely-than-not that the fair value of the intangibles are less than the respective carrying values. If the Company elects to perform or is required to perform a quantitative analysis, the test consists of a comparison of the fair value of the indefinite-lived intangible asset to the carrying value of the asset as of the impairment testing date. The Company estimates the fair value of indefinite-lived intangibles using the relief-from-royalty method, which it believes is an appropriate and widely used valuation technique for such assets. The fair value derived from the relief-from-royalty method is measured as the discounted cash flow savings realized from owning such trade names and not being required to pay a royalty for their use.
Refer to Note 11, “Goodwill and Other Intangibles,” to the Consolidated Financial Statements for more information.
Product warranties The Company provides warranties on some, but not all, of its products. The warranty terms are typically from one to three years. Provisions for estimated expenses related to product warranty are made at the time products are sold. These estimates are established using historical information about the nature, frequency and average cost of warranty claim settlements as well as product manufacturing and industry developments and recoveries from third parties. Management actively studies trends of warranty claims and takes action to improve product quality and minimize warranty claims. Costs of product recalls, which may include the cost of the product being replaced as well as the customer’s cost of the recall, including labor to remove and replace the recalled part, are accrued as part of the Company’s warranty accrual at the time an obligation becomes probable and can be
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
reasonably estimated. Management believes that the warranty accrual is appropriate; however, in certain cases, initial customer claims exceed the amount accrued. Facts may become known related to these claims that may result in additional losses that could be material to the Company’s results of operations or cash flows. The product warranty accrual is allocated to current and non-current liabilities in the Consolidated Balance Sheets.
Refer to Note 12, “Product Warranty,” to the Consolidated Financial Statements for more information.
Other loss accruals and valuation allowances The Company has numerous other loss exposures, such as customer claims, workers’ compensation claims, litigation and recoverability of certain assets. Establishing loss accruals or valuation allowances for these matters requires the use of estimates and judgment in regard to the risk exposure and ultimate realization. The Company estimates losses using consistent and appropriate methods; however, changes to its assumptions could materially affect the recorded accrued liabilities for loss or asset valuation allowances.
Environmental contingencies The Company accounts for environmental costs in accordance with ASC Topic 450, “Contingencies.” Costs related to environmental assessments and remediation efforts at operating facilities are accrued when it is probable that a liability has been incurred and the amount of that liability can be reasonably estimated. Estimated costs are recorded at undiscounted amounts, based on experience and assessments and are regularly evaluated. The liabilities are recorded in Other current and Other non-current liabilities in the Company’s Consolidated Balance Sheets and are not material.
Refer to Note 20, “Contingencies,” to the Consolidated Financial Statements for more information.
Government grants The Company periodically receives government grants representing assistance provided by a government. These government grants are generally received in cash and typically provide reimbursement related to acquisition of property and equipment, product development or local governmental economic relief. The government grants are generally amortized using a systematic and rational method over the life of the grant. As of December 31, 2023 and 2022, the Company recorded government grant related liabilities of $1 million in Other current liabilities and $6 million in Other non-current liabilities in the Company’s Consolidated Balance Sheets. During the years ended December 31, 2023 and 2022, the Company recorded $21 million and $16 million of government grant-related credits in Selling, general and administrative expenses, respectively, and $1 million and $2 million in Cost of sales, respectively, in the Company’s Consolidated Statement of Operations.
Derivative financial instruments The Company recognizes that certain normal business transactions and foreign currency operations generate risk. Examples of risks include exposure to exchange rate risk related to transactions denominated in currencies other than the functional currency, changes in commodity costs and interest rates. It is the objective of the Company to assess the impact of these transaction risks and consider mitigating such risks through various methods, including financial derivatives. Virtually all derivative instruments held by the Company are designated as hedges, have high correlation with the underlying exposure and are highly effective in offsetting underlying price movements. Accordingly, gains and losses from changes in qualifying hedge fair values are matched with the underlying transactions. Hedge instruments are generally reported gross, with no right to offset, on the Consolidated Balance Sheets at their fair value based on quoted market prices for contracts with similar maturities. The Company does not engage in any derivative transactions for purposes other than hedging specific operational risks.
Refer to Note 16, “Financial Instruments,” to the Consolidated Financial Statements for more information.
Foreign currency The financial statements of foreign subsidiaries are translated to U.S. Dollars using the period-end exchange rate for assets and liabilities and an average exchange rate for each period for revenues, expenses and capital expenditures. The local currency is the functional currency for substantially all of the Company's foreign subsidiaries. Translation adjustments for foreign subsidiaries are recorded as a component of Accumulated other comprehensive (loss) income in equity. The Company recognizes transaction gains and losses arising from fluctuations in currency exchange rates on transactions denominated in currencies other than the functional currency in earnings as incurred.
Refer to Note 19, “Accumulated Other Comprehensive Loss,” to the Consolidated Financial Statements for more information.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Pensions The Company’s defined benefit pension plans are accounted for in accordance with ASC Topic 715. Disability early retirement benefits are accounted for in accordance with ASC Topic 712.
Pension costs and related liabilities and assets are dependent upon assumptions used in calculating such amounts. These assumptions include discount rates, expected returns on plan assets, health care cost trends, compensation and other factors. In accordance with U.S. GAAP, actual results that differ from the assumptions used are accumulated and amortized over future periods, and accordingly, generally affect recognized expense in future periods.
Refer to Note 17, “Retirement Benefit Plans,” to the Consolidated Financial Statements for more information.
Restructuring Restructuring costs may occur when the Company takes action to exit or significantly curtail a part of its operations or implements a reorganization that affects the nature and focus of operations. A restructuring charge can consist of severance costs associated with reductions to the workforce, costs to terminate an operating lease or contract, professional fees and other costs incurred related to the implementation of restructuring activities.
The Company generally records costs associated with voluntary separations at the time of employee acceptance. Costs for involuntary separation programs are recorded when management has approved the plan for separation, the employees are identified and aware of the benefits they are entitled to and it is unlikely that the plan will change significantly. When a plan of separation requires approval by or consultation with the relevant labor organization or government, the costs are recorded upon agreement. Costs associated with benefits that are contingent on the employee continuing to provide service are accrued over the required service period.
Refer to Note 3, “Restructuring,” to the Consolidated Financial Statements for more information.
Income taxes The Company accounts for income taxes in accordance ASC Topic 740 (ASC 740). Income taxes as presented in the Company’s Consolidated Financial Statements have been allocated in a manner that is systematic, rational, and consistent with the broad principles of ASC 740. Historically, the Company’s operations have been included in BorgWarner’s U.S. federal consolidated tax return, certain foreign tax returns, and certain state tax returns. For the purposes of the 2022 and 2021 financial statements, the Company’s income tax provision was computed as if the Company filed separate tax returns (i.e., as if the Company had not been included in the consolidated income tax return group with BorgWarner). The separate-return method applies ASC 740 to the Combined Financial Statements of each member of a consolidated tax group as if the group member were a separate taxpayer.
In accordance with ASC 740, the Company’s income tax expense is calculated based on expected income and statutory tax rates in the various jurisdictions in which the Company operates and requires the use of management’s estimates and judgments. Accounting for income taxes is complex, in part because the Company conducts business globally and, therefore, files income tax returns in numerous tax jurisdictions. Management judgment is required in determining the Company’s worldwide provision for income taxes and recording the related assets and liabilities, including accruals for unrecognized tax benefits and assessing the need for valuation allowances.
The determination of accruals for unrecognized tax benefits includes the application of complex tax laws in a multitude of jurisdictions across the Company’s global operations. Management judgment is required in determining the gross unrecognized tax benefits’ related liabilities. In the ordinary course of the Company’s business, there are many transactions and calculations where the ultimate tax determination is less than certain. Accruals for unrecognized tax benefits are established when, despite the belief that tax positions are supportable, there remain certain positions that do not meet the minimum probability threshold, which is a tax position that is more-likely-than-not to be sustained upon examination by the applicable taxing authority.
The Company records valuation allowances to reduce the carrying value of deferred tax assets to amounts that it expects are more-likely-than-not to be realized. The Company assesses existing deferred tax assets, net operating losses, and tax credits by jurisdiction and expectations of its ability to utilize these tax attributes through a review of past, current and estimated future taxable income and tax planning strategies.
Refer to Note 6, “Income Taxes,” to the Consolidated Financial Statements for more information.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
New Accounting Pronouncements
Accounting Standards Not Yet Adopted
Accounting Standards Update (ASU) 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” It is intended to improve disclosures about a public entity’s reportable segments and addresses requests from investors and other allocators of capital for additional, more detailed information about a reportable segment’s expenses. This guidance is effective for annual reporting periods beginning after December 15, 2023 and interim reporting periods beginning after December 15, 2024. The Company does not expect this guidance to have a material impact on its Consolidated Financial Statements.
ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” It requires entities to disaggregate information related to the effective tax rate reconciliation and income taxes paid. The standard improves transparency by providing more detailed income tax disclosures that would be useful in making capital allocation decisions. This guidance is effective for annual reporting periods beginning after December 15, 2024. The Company does not expect this guidance to have a material impact on its Consolidated Financial Statements.
NOTE 2 REVENUE FROM CONTRACTS WITH CUSTOMERS
The Company manufactures and sells products, primarily to OEMs of commercial vehicle industrial applications and light vehicles, to certain Tier One vehicle systems suppliers and into the aftermarket. The Company’s payment terms are based on customary business practices and vary by customer type and products offered. The Company has evaluated the terms of its arrangements and determined that they do not contain significant financing components.
Generally, revenue is recognized upon shipment or delivery; however, a limited number of the Company’s customer arrangements for its highly customized products with no alternative use provide the Company with the right to payment during the production process. As a result, for these limited arrangements, revenue is recognized as goods are produced and control transfers to the customer using the input cost-to-cost method. The Company recorded a contract asset of $1 million and $2 million at December 31, 2023 and 2022, respectively, for these arrangements. These amounts are reflected in Prepayments and other current assets in the Company’s Consolidated Balance Sheets.
In limited instances, certain customers have provided payments in advance of receiving related products, typically at the onset of an arrangement prior to the beginning of production. These contract liabilities are reflected as Other current liabilities in the Consolidated Balance Sheets and were $6 million at December 31, 2023 and $3 million at December 31, 2022. These amounts are reflected as revenue over the term of the arrangement (typically three to seven years) as the underlying products are shipped and represent the Company’s remaining performance obligations as of the end of the period.
The following table represents a disaggregation of revenue from contracts with customers by reportable segment and region for the years ended December 31, 2023, 2022, and 2021. Refer to Note 24, Reportable Segments and Related Information to the Consolidated Financial Statements for more information.
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, 2023 |
(In millions) | Fuel Systems | | Aftermarket | | Total |
Americas | $ | 712 | | | $ | 776 | | | $ | 1,488 | |
Europe | 953 | | | 472 | | | 1,425 | |
Asia | 512 | | | 75 | | | 587 | |
Total | $ | 2,177 | | | $ | 1,323 | | | $ | 3,500 | |
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, 2022 |
(In millions) | Fuel Systems | | Aftermarket | | Total |
Americas | $ | 559 | | | $ | 811 | | | $ | 1,370 | |
Europe | 904 | | | 401 | | | 1,305 | |
Asia | 609 | | | 64 | | | 673 | |
Total | $ | 2,072 | | | $ | 1,276 | | | $ | 3,348 | |
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, 2021 |
(In millions) | Fuel Systems | | Aftermarket | | Total |
Americas | $ | 366 | | | $ | 727 | | | $ | 1,093 | |
Europe | 1,006 | | | 423 | | | 1,429 | |
Asia | 644 | | | 61 | | | 705 | |
Total | $ | 2,016 | | | $ | 1,211 | | | $ | 3,227 | |
NOTE 3 RESTRUCTURING
The Company’s restructuring activities are undertaken as necessary to execute management’s strategy and streamline operations, consolidate and take advantage of available capacity and resources, and ultimately achieve net cost reductions. Restructuring activities include efforts to integrate and rationalize the Company’s business and to relocate operations to best-cost locations.
The Company’s restructuring expenses consist primarily of employee termination benefits (principally severance and/or other termination benefits) and other costs, which are primarily professional fees and costs related to equipment moves.
The following table displays a roll forward of the restructuring liability recorded within the Company’s Consolidated Balance Sheets and the related cash flow activity:
| | | | | | | | | | | | | | | | | |
(in millions) | Employee Termination Benefits | | Other | | Total |
Balance, January 1, 2022 | $ | 60 | | | $ | — | | | $ | 60 | |
Restructuring expense, net | 2 | | | 9 | | | 11 | |
Cash payments | (41) | | | (9) | | | (50) | |
Foreign currency translation adjustment and other | (1) | | | — | | | (1) | |
Balance, December 31, 2022 | 20 | | | — | | | 20 | |
Restructuring expense, net | 9 | | | 3 | | | 12 | |
Cash payments | (20) | | | (3) | | | (23) | |
Foreign currency translation adjustment and other | — | | | 1 | | | 1 | |
Balance, December 31, 2023 | $ | 9 | | | $ | 1 | | | $ | 10 | |
Less: Non-current restructuring liability | 1 | | | — | | | 1 | |
Current restructuring liability at December 31, 2023 | $ | 8 | | | $ | 1 | | | $ | 9 | |
During 2023, the Company approved individual restructuring actions that primarily related to reductions in headcount in the Fuel Systems segment and recorded $12 million of restructuring expense related to these actions.
In 2019, the Company announced a restructuring plan to reshape and realign its global technical center footprint and reduce salaried and contract staff. The Fuel Systems segment recorded charges of $5 million and $55 million during the years ended December 31, 2022 and 2021, respectively, primarily for the statutory minimum benefits and
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
incremental one-time termination benefits negotiated with local labor authorities. The majority of the actions under this program have been completed.
Estimates of restructuring expense are based on information available at the time such charges are recorded. Due to the inherent uncertainty involved in estimating restructuring expenses, actual amounts paid for such activities may differ from amounts initially recorded. Accordingly, the Company may record revisions of previous estimates by adjusting previously established accruals.
The Company continues to evaluate different options across its operations to reduce existing structural costs over the next few years. The Company will recognize restructuring expense associated with any future actions at the time they are approved and become probable or are incurred. Any future actions could result in significant restructuring expense.
NOTE 4 RESEARCH AND DEVELOPMENT COSTS
The Company’s net Research & Development (R&D) expenditures are primarily included in Selling, general and administrative expenses of the Consolidated Statements of Operations. Customer reimbursements are netted against gross R&D expenditures as they are considered a recovery of cost. Customer reimbursements for prototypes are recorded net of prototype costs based on customer contracts, typically either when the prototype is shipped or when it is accepted by the customer. Customer reimbursements for engineering services are recorded when performance obligations are satisfied in accordance with the contract. Financial risks and rewards transfer upon shipment, acceptance of a prototype component by the customer or upon completion of the performance obligation as stated in the respective customer agreement. The Company has various customer arrangements relating to R&D activities that it performs at its various R&D locations.
The following table presents the Company’s gross and net expenditures on R&D activities:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
(in millions) | 2023 | | 2022 | | 2021 |
Gross R&D expenditures | $ | 188 | | | $ | 200 | | | $ | 247 | |
Customer reimbursements | (80) | | | (96) | | | (115) | |
Net R&D expenditures | $ | 108 | | | $ | 104 | | | $ | 132 | |
Net R&D expenditures as a percentage of net sales were 3.1%, 3.1% and 4.1% for the years ended December 31, 2023, 2022 and 2021, respectively.
NOTE 5 OTHER OPERATING EXPENSE (INCOME), NET
Items included in Other operating expense (income), net consist of:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
(in millions) | 2023 | | 2022 | | 2021 |
Royalty income from Former Parent | $ | (17) | | | $ | (31) | | | $ | (22) | |
R&D income from Former Parent | (2) | | | (11) | | | (10) | |
Separation and transaction costs | 80 | | | 31 | | | 7 | |
| | | | | |
Asset impairments | — | | | 5 | | | 14 | |
Other operating income, net | (3) | | | (9) | | | (2) | |
Other operating expense (income), net | $ | 58 | | | $ | (15) | | | $ | (13) | |
Royalty income from Former Parent: The Company participated in royalty arrangements with BorgWarner businesses prior to the Spin-Off, which involved the licensing of the Delphi Technologies trade name and product-related intellectual properties. For the years ended December 31, 2023, 2022 and 2021, the Company recognized
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
royalty income from BorgWarner businesses in the amount of $17 million, $31 million and $22 million, respectively. Refer to Note 23, “Related Party," for further information.
R&D income from Former Parent: The Company provided application testing and other R&D services for other BorgWarner businesses prior to the Spin-Off. For the years ended December 31, 2023, 2022 and 2021, the Company recognized income related to these services of $2 million, $11 million and $10 million, respectively. Refer to Note 23, "Related Party," for further information.
Separation and transaction costs: During the year ended December 31, 2023 and 2022, the Company recorded separation costs of $80 million and $31 million, respectively, primarily related to professional fees associated with the intended separation of the Company. During the year ended December 31, 2021, the Company recorded transaction costs of $7 million primarily related to professional fees associated with the acquisition, integration and other support of the Company's acquisition of Delphi Technologies.
Asset impairments: During the year ended December 31, 2022, the Company wound down its Aftermarket operation in Russia and recorded an impairment expense of $5 million for the impairment of an intangible asset related to this business. During the year ended December 31, 2021, the Company performed a quantitative impairment test over an indefinite-lived trade name in the Aftermarket segment. The impairment test indicated that the fair value was less than the carrying value due to a decrease in expected revenues associated with the trade name. Therefore, the Company recorded an impairment charge of $14 million. Refer to Note 11 “Goodwill and Other Intangibles,” to the Consolidated Financial Statement for more information.
NOTE 6 INCOME TAXES
Earnings before income taxes and the provision for income taxes are presented in the following table.
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
(in millions) | 2023 | | 2022 | | 2021 |
Earnings before income taxes: | | | | | |
U.S. | $ | (18) | | | $ | 90 | | | $ | 43 | |
Non-U.S. | 224 | | | 257 | | | 143 | |
Total | $ | 206 | | | $ | 347 | | | $ | 186 | |
Provision for income taxes: | | | | | |
Current: | | | | | |
Federal | $ | 22 | | | $ | 28 | | | $ | 15 | |
State | 2 | | | 1 | | | 2 | |
Foreign | 48 | | | 31 | | | 72 | |
Total current expense | 72 | | | 60 | | | 89 | |
Deferred: | | | | | |
Federal | (14) | | | (12) | | | (7) | |
State | (2) | | | (1) | | | (1) | |
Foreign | 48 | | | 38 | | | (48) | |
Total deferred expense (benefit) | 32 | | | 25 | | | (56) | |
Total provision for income taxes | $ | 104 | | | $ | 85 | | | $ | 33 | |
The provision for income taxes resulted in an effective tax rate of approximately 50%, 24% and 18% for the years ended December 31, 2023, 2022 and 2021, respectively.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The following table provides a reconciliation of tax expense based on the U.S. statutory tax rate to final tax expense.
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
(in millions) | 2023 | | 2022 | | 2021 |
Income taxes at U.S. statutory rate of 21% | $ | 43 | | | $ | 73 | | | $ | 39 | |
Increases (decreases) resulting from: | | | | | |
Valuation allowance adjustments, net | 63 | | | 37 | | | 38 | |
Net tax on remittance of foreign earnings | 29 | | | 12 | | | 10 | |
Non-deductible transaction costs | 10 | | | — | | | — | |
Changes in accounting methods and filing positions | (2) | | | 2 | | | (1) | |
U.S. tax on foreign earnings | 12 | | | — | | | — | |
Foreign rate differentials | (3) | | | 3 | | | (5) | |
Impact of tax law and rate changes | (1) | | | — | | | (21) | |
State taxes, net of federal benefit | (1) | | | (1) | | | — | |
| | | | | |
| | | | | |
Tax holidays | (6) | | | (8) | | | (8) | |
Enhanced research and development deductions | (8) | | | (9) | | | (10) | |
Reserve adjustments, settlements and claims | (7) | | | (7) | | | 3 | |
Non-taxable interest income | (29) | | | (15) | | | (14) | |
Other, net | 4 | | | (2) | | | 2 | |
Provision for income taxes, as reported | $ | 104 | | | $ | 85 | | | $ | 33 | |
The Company’s effective tax rate was impacted beneficially by certain entities in China with the High and New Technology Enterprise (HNTE) status. The income tax benefit for HNTE status was approximately $6 million, $8 million and $8 million for the years ended December 31, 2023, 2022 and 2021, respectively. HNTE status is granted for three-year periods, and the Company seeks to renew such status on a regular basis.
For the year ended December 31, 2023, the Company’s effective tax rate increased compared to the year ended December 31, 2022 as a result of a change in the jurisdictional mix of pre-tax earnings, most notably an increase in pre-tax losses where no tax benefit is recognized. In addition, the Company recognized increases in its U.S. taxes on foreign earnings based on the post Spin-Off structure. During 2023, the Company recognized discrete tax benefits of $2 million, primarily due to structural changes concluded in the fourth quarter.
During 2022, the Company recognized discrete tax benefits of $7 million, primarily due to certain unrecognized tax benefits and accrued interest related to a matter for which the statute of limitations had lapsed.
In 2021, the Company recognized a discrete tax benefit of $21 million related to an increase in its deferred tax assets as a result of an increase in the United Kingdom tax rate from 19% to 25%. This rate change was enacted in June 2021 and became effective April 2023.
The Company recognizes taxes due under the Global Intangible Low-Taxed Income (GILTI) provision as a current period expense.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
A roll forward of the Company’s total gross unrecognized tax benefits is presented below:
| | | | | | | | | | | | | | | | | |
(in millions) | 2023 | | 2022 | | 2021 |
Balance, January 1 | $ | 35 | | | $ | 64 | | | $ | 56 | |
Additions based on tax positions related to current year | 1 | | | 2 | | | 3 | |
Additions for tax positions of prior years | 1 | | | — | | | — | |
Reductions for lapse in statute of limitations | — | | | (14) | | | — | |
Reductions for closure of tax audits and settlements | (2) | | | (12) | | | — | |
Reductions for tax positions of prior years | (11) | | | (1) | | | — | |
(Distributions) Acquisitions | (14) | | | — | | | 8 | |
Translation adjustment | 1 | | | (4) | | | (3) | |
Balance, December 31 | $ | 11 | | | $ | 35 | | | $ | 64 | |
The Company recognizes interest and penalties related to unrecognized tax benefits in income tax expense. For each of the years ended December 31, 2023, 2022 and 2021, the Company recognized approximately $1 million. The Company has an accrual of approximately $4 million and $2 million for the payment of interest and penalties at December 31, 2023 and 2022, respectively. As of December 31, 2023, approximately $15 million represents the amount that, if recognized, would affect the Company's effective income tax rate in future periods. The Company estimates that it is reasonably possible there could be a decrease of less than $1 million in unrecognized tax benefits and interest in the next 12 months related to the closure of an audit and the lapse in statute of limitations subsequent to the reporting period from certain taxing jurisdictions.
The Company and/or one of its subsidiaries files income tax returns in the U.S. federal, various state jurisdictions and various foreign jurisdictions. In certain tax jurisdictions, the Company may have more than one taxpayer. The PHINIA U.S. group will file its first U.S. federal tax return in 2024; therefore, there are not open years subject to Internal Revenue Service (IRS) audit. The Company is no longer subject to income tax examinations by tax authorities in its major tax jurisdictions as follows:
| | | | | | | | | | | | | | | | | | | | |
Tax jurisdiction | | Years no longer subject to audit | | Tax jurisdiction | | Years no longer subject to audit |
United Kingdom | | 2016 and prior | | Turkey | | 2017 and prior |
Mexico | | 2016 and prior | | Luxembourg | | 2017 and prior |
China | | 2016 and prior | | Poland | | 2017 and prior |
France | | 2016 and prior | | Romania | | 2017 and prior |
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The components of deferred tax assets and liabilities consist of the following:
| | | | | | | | | | | |
| December 31, |
(in millions) | 2023 | | 2022 |
Deferred tax assets: | | | |
Net operating loss and capital loss carryforwards | $ | 252 | | | $ | 474 | |
Interest limitation carryforwards | 188 | | | 158 | |
| | | |
Accrued expenses | 24 | | | 62 | |
Pension | 35 | | | 31 | |
Employee compensation | 12 | | | 6 | |
Warranty | 11 | | | 10 | |
| | | |
| | | |
Unrecognized tax benefits | — | | | 2 | |
| | | |
| | | |
Other | 46 | | | 15 | |
Total deferred tax assets | $ | 568 | | | $ | 758 | |
Valuation allowances | (413) | | | (478) | |
Net deferred tax asset | $ | 155 | | | $ | 280 | |
Deferred tax liabilities: | | | |
Goodwill and intangible assets | $ | (51) | | | $ | (72) | |
Unremitted foreign earnings | (50) | | | (16) | |
| | | |
Unrealized gain on equity securities | (4) | | | (5) | |
Fixed assets | (15) | | | (9) | |
Other | (29) | | | (67) | |
Total deferred tax liabilities | (149) | | | (169) | |
Net deferred taxes | $ | 6 | | | $ | 111 | |
As of December 31, 2023, certain non-U.S. operations had net operating loss carryforwards totaling $956 million available to offset future taxable income. Of the total $956 million, $924 million expire at various dates from 2024 through 2043, and the remaining $32 million have no expiration date. The Company has a valuation allowance against $929 million of certain non-U.S. net operating loss carryforwards.
The Company reviews the likelihood that the benefit of its deferred tax assets will be realized and, therefore, the need for valuation allowances on a quarterly basis. The Company assesses existing deferred tax assets, net operating loss carryforwards, and tax credit carryforwards by jurisdiction and expectations of its ability to utilize these tax attributes through a review of past, current, and estimated future taxable income and tax planning strategies. If, based upon the weight of available evidence, it is more-likely-than-not the deferred tax assets will not be realized, a valuation allowance is recorded. Due to recent restructurings, the Company concluded that the weight of the negative evidence outweighs the positive evidence in certain foreign jurisdictions. As a result, the Company believes it is more-likely-than-not that the net deferred tax assets in certain foreign jurisdictions that include entities in Luxembourg and the U.K. will not be realized in the future.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The following table represents a summary of the valuation allowances against deferred tax assets as of and for the three years December 31, 2023, 2022, and 2021:
| | | | | | | | | | | | | | | | | |
(in millions) | 2023 | | 2022 | | 2021 |
Beginning balance, January 1 | $ | 478 | | | $ | 466 | | | $ | 447 | |
Establishment of new allowances1 | 3 | | | — | | | — | |
Net change to existing allowances2 | 60 | | | 37 | | | 27 | |
Opening balance sheet equity/other3 | (110) | | | — | | | — | |
Foreign currency translation | (18) | | | (25) | | | (8) | |
Ending balance, December 31 | $ | 413 | | | $ | 478 | | | $ | 466 | |
_____________________________
1 Reflects valuation allowances initially established as a result of a change in management’s judgment regarding the realizability of deferred tax assets.
2 Reflects movements in previously established valuation allowances, which increase or decrease as the related deferred tax assets increase or decrease. Such movements occur as a result of a change in management’s judgment regarding previously established valuation allowances, remeasurement due to a tax rate change and changes in the underlying attributes of the deferred tax assets, including expiration of the attribute and reversal of the temporary difference that gave rise to the deferred tax asset.
3 Reflects movements in previously established valuation allowances primarily recorded to equity as result of the Spin-Off.
As of December 31, 2023, the Company recorded deferred tax liabilities of $50 million with respect to foreign unremitted earnings. The Company did not provide deferred tax liabilities with respect to certain book versus tax basis differences not represented by undistributed earnings of approximately $420 million as of December 31, 2023, because the Company continues to assert indefinite reinvestment of these basis differences. These basis differences would become taxable upon the sale or liquidation of the foreign subsidiaries. Based on the Company's structure, it is impracticable to determine the unrecognized deferred tax liability on these earnings. Actual tax liability, if any, would be dependent on circumstances existing when a repatriation, sale, or liquidation occurs.
NOTE 7 RECEIVABLES, NET
The table below provides details of receivables as of December 31, 2023 and 2022:
| | | | | | | | | | | |
| December 31, |
(in millions) | 2023 | | 2022 |
Receivables, net: | | | |
Customers | $ | 658 | | | $ | 620 | |
Indirect taxes | 167 | | | 87 | |
Due from Former Parent | 146 | | | 142 | |
Other | 57 | | | 49 | |
Gross receivables | 1,028 | | | 898 | |
Allowance for credit losses | (11) | | | (7) | |
Total receivables, net | $ | 1,017 | | | $ | 891 | |
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The table below summarizes the activity in the allowance for credit losses for the years ended December 31, 2023, 2022 and 2021:
| | | | | | | | | | | | | | | | | |
| |
(in millions) | 2023 | | 2022 | | 2021 |
Beginning balance, January 1 | $ | (7) | | | $ | (4) | | | $ | — | |
Provision | (8) | | | (4) | | | (4) | |
Write-offs | 4 | | | — | | | — | |
| | | | | |
Translation adjustment and other | — | | | 1 | | | — | |
Ending balance, December 31 | $ | (11) | | | $ | (7) | | | $ | (4) | |
Factoring
The Company has arrangements with various financial institutions to sell eligible trade receivables from certain customers in North America and Europe. These arrangements can be terminated at any time subject to prior written notice. The receivables under these arrangements are sold without recourse to the Company and are, therefore, accounted for as true sales. During the years ended December 31, 2023, 2022 and 2021, the Company sold $152 million, $142 million and $156 million of receivables, respectively, under these arrangements. Additionally, during the same periods, expenses of $9 million, $5 million and $3 million, respectively, were recognized within interest expense.
NOTE 8 INVENTORIES
A summary of Inventories is presented below: | | | | | | | | | | | |
| December 31, |
(in millions) | 2023 | | 2022 |
Raw material and supplies | $ | 286 | | | $ | 275 | |
Work-in-progress | 46 | | | 39 | |
Finished goods | 155 | | | 145 | |
Inventories | $ | 487 | | | $ | 459 | |
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 9 OTHER CURRENT AND NON-CURRENT ASSETS
| | | | | | | | | | | |
| December 31, |
(in millions) | 2023 | | 2022 |
Prepayments and other current assets: | | | |
Prepaid taxes | $ | 26 | | | $ | 11 | |
Customer return assets | 8 | | | 6 | |
Prepaid software | 5 | | | — | |
Prepaid engineering | 3 | | | 3 | |
Deposits | 3 | | | 3 | |
Prepaid customer tooling | 3 | | | 3 | |
Prepaid insurance | 3 | | | — | |
| | | |
| | | |
Other | 7 | | | 14 | |
Total prepayments and other current assets | $ | 58 | | | $ | 40 | |
| | | |
Investments and long-term receivables: | | | |
Investment in equity affiliates | $ | 48 | | | $ | 44 | |
Due from Former Parent | 41 | | | 208 | |
| | | |
Long-term receivables | 22 | | | 71 | |
Investment in equity securities | 4 | | | 2 | |
Total investments and long-term receivables | $ | 115 | | | $ | 325 | |
| | | |
Other non-current assets: | | | |
Operating leases (Note 21) | $ | 63 | | | $ | 82 | |
Deferred income taxes (Note 6) | 61 | | | 157 | |
Customer incentive payments | 10 | | | — | |
| | | |
Other | 28 | | | 25 | |
Total other non-current assets | $ | 162 | | | $ | 264 | |
NOTE 10 PROPERTY, PLANT AND EQUIPMENT, NET
Property, plant and equipment, net is stated at cost less accumulated depreciation and amortization, and consisted of:
| | | | | | | | | | | |
| December 31, |
(in millions) | 2023 | | 2022 |
Land, land use rights and buildings | $ | 250 | | | $ | 228 | |
Machinery and equipment | 1,031 | | | 936 | |
| | | |
Construction in progress | 79 | | | 81 | |
Total property, plant and equipment, gross | 1,360 | | | 1,245 | |
Less: accumulated depreciation | 481 | | | 369 | |
Property, plant and equipment, net, excluding tooling | 879 | | | 876 | |
Tooling, net of amortization | 42 | | | 46 | |
Property, plant and equipment, net | $ | 921 | | | $ | 922 | |
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 11 GOODWILL AND OTHER INTANGIBLES
The Company’s goodwill is tested for impairment annually in the fourth quarter for all reporting units, and more frequently if events or circumstances warrant such a review. The Company performed the two-step impairment testing during the fourth quarter of 2023 to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. The estimated fair value was determined using a combined income and market approach. The market approach is based on market multiples (revenue and “EBITDA”, defined as earnings before interest, taxes, depreciation and amortization) and requires an estimate of appropriate multiples based on market data for comparable companies. The market valuation models and other financial ratios used by the Company require certain assumptions and estimates regarding the applicability of those models to the Company’s facts and circumstances.
The Company believes the assumptions and estimates used to determine the estimated fair value are reasonable. Different assumptions could materially affect the estimated fair value. The primary assumptions affecting the Company’s 2023 goodwill quantitative impairment review are as follows:
•Discount rates: The Company used weighted average cost of capital (“WACC”) as the discount rates for future cash flows. The WACC is intended to represent a rate of return that would be expected by a market participant.
•EBITDA margins: The Company used historical and expected EBITDA margins, which may vary based on the projections of the reporting unit being evaluated.
•Revenue growth rates: The Company used a global automotive market industry growth rate forecast adjusted to estimate its own market participation for product lines.
•Market multiples: The Company used appropriate multiples based on market data for comparable companies.
In addition to the above primary assumptions, the Company notes the following risks to volume and operating income assumptions that could have an impact on the discounted cash flow models:
•The automotive industry is cyclical, and the Company’s results of operations could be adversely affected by industry downturns.
•The automotive industry is evolving, and if the Company does not respond appropriately, its results of operations could be adversely affected.
•The Company is dependent on market segments that use its key products and could be affected by decreasing demand in those segments.
•The Company is subject to risks related to international operations.
The results of the impairment testing performed indicated that the estimated fair value of the Aftermarket reporting unit exceeded its carrying value by a considerable amount, and the estimated fair value of the Fuel Systems reporting unit exceeded its carrying value by less than 10%. It was determined that it is more likely than not that the estimated fair value of each reporting unit exceeded its respective carrying value and as such, the Company’s goodwill was not considered impaired as of the fourth quarter of 2023.
Future changes in the judgments, assumptions and estimates from those used in acquisition-related valuations and goodwill impairment testing, including discount rates or future operating results and related cash flow projections, could result in significantly different estimates of the fair values in the future. An increase in discount rates, a reduction in projected cash flows or a combination of the two could lead to a reduction in the estimated fair values, which may result in impairment charges that could materially affect the Company’s financial statements in any given year.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
A summary of the changes in the carrying amount of goodwill is presented in the following tables. The Company has determined that each of the reportable segments are each also a reporting unit. Refer to Note 24, “Reportable Segments and Related Information” for more information.
| | | | | | | | | | | | | | | | | | | | | | | |
| 2023 | | 2022 |
(in millions) | Fuel Systems | | Aftermarket | | Fuel Systems | | Aftermarket |
Gross goodwill balance, January 1 | $ | 58 | | | $ | 545 | | | $ | 58 | | | $ | 551 | |
Accumulated impairment losses, January 1 | — | | | (113) | | | — | | | (113) | |
Net goodwill balance, January 1 | $ | 58 | | | $ | 432 | | | $ | 58 | | | $ | 438 | |
Goodwill during the year: | | | | | | | |
| | | | | | | |
Translation adjustment | 3 | | | 6 | | | — | | | (6) | |
Net goodwill balance, December 31 | $ | 61 | | | $ | 438 | | | $ | 58 | | | $ | 432 | |
The Company’s other intangible assets, primarily from acquisitions, consist of the following:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | December 31, 2023 | | December 31, 2022 |
(in millions) | Estimated useful lives (years) | | Gross carrying amount | | Accumulated amortization | | Net carrying amount | | Gross carrying amount | | Accumulated amortization | | Net carrying amount |
Amortized intangible assets: | | | | | | | | | | | | | |
Patented and unpatented technology | 14 - 15 | | $ | 149 | | | $ | 41 | | | $ | 108 | | | $ | 144 | | | $ | 30 | | | $ | 114 | |
Customer relationships | 14 - 15 | | 268 | | | 104 | | | 164 | | | 263 | | | 85 | | | 178 | |
Total amortized intangible assets | | | 417 | | | 145 | | | 272 | | | 407 | | | 115 | | | 292 | |
Unamortized trade names | | | 145 | | | — | | | 145 | | | 140 | | | — | | | 140 | |
Total other intangible assets | | | $ | 562 | | | $ | 145 | | | $ | 417 | | | $ | 547 | | | $ | 115 | | | $ | 432 | |
Amortization of other intangible assets was $28 million, $28 million and $29 million for the years ended December 31, 2023, 2022 and 2021, respectively. The Company utilizes the straight-line method of amortization recognized over the estimated useful lives of the assets. The estimated future annual amortization expense, primarily for acquired intangible assets, is $28 million for each of the years 2024 through 2028 and $132 million thereafter.
A roll forward of the gross carrying amounts and related accumulated amortization of the Company’s other intangible assets is presented below:
| | | | | | | | | | | | | | | | | | | | | | | |
| Gross carrying amounts | | Accumulated amortization |
(in millions) | 2023 | | 2022 | | 2023 | | 2022 |
Beginning balance, January 1 | $ | 547 | | | $ | 558 | | | $ | 115 | | | $ | 88 | |
Impairment1 | — | | | (6) | | | — | | | (1) | |
Amortization | — | | | — | | | 28 | | | 28 | |
Translation adjustment | 15 | | | (5) | | | 2 | | | — | |
Ending balance, December 31 | $ | 562 | | | $ | 547 | | | $ | 145 | | | $ | 115 | |
_____________________________
1 In 2022, the Company wound down its business in Russia.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 12 PRODUCT WARRANTY
The following table summarizes the activity in the product warranty accrual accounts:
| | | | | | | | | | | |
(in millions) | 2023 | | 2022 |
Beginning balance, January 1 | $ | 60 | | | $ | 68 | |
Provisions for current period sales | 43 | | | 36 | |
Adjustments of prior estimates | (2) | | | 5 | |
Payments | (45) | | | (47) | |
Other, primarily translation adjustment | — | | | (2) | |
Ending balance, December 31 | $ | 56 | | | $ | 60 | |
The product warranty liability is classified in the Consolidated Balance Sheets as follows:
| | | | | | | | | | | |
| December 31, |
(in millions) | 2023 | | 2022 |
Other current liabilities | $ | 30 | | | $ | 32 | |
Other non-current liabilities | 26 | | | 28 | |
Total product warranty liability | $ | 56 | | | $ | 60 | |
NOTE 13 NOTES PAYABLE AND DEBT
The Company had short-term and long-term debt outstanding as follows:
| | | | | | | | | | | |
| December 31, |
(in millions) | 2023 | | 2022 |
Short-term debt | | | |
Short-term borrowings | $ | 75 | | | $ | — | |
| | | |
Long-term debt | | | |
5.000% Senior notes due 10/1/2025 ($800 million par value) | $ | 25 | | | $ | 26 | |
Term Loan A Facility (net of $3 unamortized issuance costs) | 295 | | | — | |
Term Loan B Facility (net of $6 unamortized issuance costs and $15 unamortized discount) | 403 | | | — | |
| | | |
Total long-term debt | $ | 723 | | | $ | 26 | |
Less: current portion | 14 | | | — | |
Long-term debt, net of current portion | $ | 709 | | | $ | 26 | |
The Company utilizes its committed revolving credit facility for short-term working capital requirements. As of December 31, 2023, the Company had $75 million in borrowings under these facilities, which are reported in Short-term borrowings and current portion of long-term debt on the Consolidated Balance Sheets.
The weighted average interest rate on short-term borrowings outstanding as of December 31, 2023 was 7.9%. The weighted average interest rate on all borrowings outstanding as of December 31, 2023 and 2022 was 8.8% and 5.0%, respectively.
Credit Agreement
On July 3, 2023, the Company entered into a $1.225 billion Credit Agreement consisting of a $500 million revolving credit facility (the “Revolving Facility”), a $300 million Term Loan A Facility (the “Term Loan A Facility”) and a $425 million Term Loan B Facility (the “Term Loan B Facility”; together with the Revolving Facility and the Term Loan
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
A Facility, collectively, the “Facilities”) in connection with the Spin-Off that occurred on the same date. Subject to extension by the lenders, at their option, upon the Company’s request, the Facilities mature on July 3, 2028; provided, however, that if earlier, the Revolving Facility and the Term Loan A Facility will mature 91 calendar days prior to the scheduled maturity of the Term Loan B Facility or any refinancing or replacement thereof in an aggregate principal amount exceeding $100 million that is secured pari passu with the Revolving Facility and the Term Loan A Facility and matures on or prior to July 3, 2028.
Borrowings under the Credit Agreement bear interest at varying rates, depending on the type of loan and, in some cases, the rates of designated benchmarks and the Company’s related election. For borrowings under the Credit Agreement, the Company may choose among the following interest rates: (i) solely in the case of U.S. dollar-denominated loans, an interest rate equal to the highest of (1) the prime rate in effect from time to time, (2) the federal funds effective rate in effect from time to time plus 0.5%, (3) adjusted term Secured Overnight Financing Rate (SOFR) (which includes a 0.10% credit spread adjustment to term SOFR) for a one month interest period plus 1.00%, and (4) 1.00%, in each case plus a rate (x) with respect to the Revolving Facility and the Term Loan A Facility, ranging from 1.50% to 2.00% depending on the Company’s consolidated net leverage ratio or (y) with respect to the Term Loan B Facility, 3.00%; or (ii) an interest rate equal to (1) solely in the case of U.S. dollar-denominated loans, adjusted term SOFR, (2) solely in the case of euro-denominated loans, Euro Interbank Offered Rate (EURIBOR), or (3) solely in the case of pound sterling-denominated loans, adjusted Sterling Overnight Index Average Reference Rate (SONIA) (which includes a 0.0326% credit spread adjustment to SONIA), as applicable, in each case for the applicable interest period plus a rate (x) with respect to adjusted term SOFR for the Revolving Facility and the Term Loan A Facility, EURIBOR and SONIA, ranging from 2.50% to 3.00% depending on our consolidated net leverage ratio, and (y) with respect to adjusted term SOFR for the Term Loan B Facility, 4.00%. Additionally, the Company will pay a quarterly commitment fee based on the actual daily amount of the available Revolving Facility commitment.
Proceeds of the Term Loan A Facility and the Term Loan B Facility were used only for certain payments in connection with the Spin-Off and the Credit Agreement. Proceeds of the Revolving Facility were used for certain payments in connection with the Spin-Off and the Credit Agreement and for working capital and general corporate purposes.
As of December 31, 2023, the Company had $75 million of outstanding borrowings under the Revolving Facility. The Credit Agreement contains customary covenants relating to us and our subsidiaries concerning, among other things, investments, dispositions of assets, indebtedness, liens on assets, and dividends and other distributions. Solely in respect of the Revolving Facility and the Term Loan A Facility, the Credit Agreement also contains financial covenants requiring (i) the consolidated net leverage ratio of the Company, determined as of the end of each fiscal quarter, not to exceed 3.00 to 1.00 (or, at our election and subject to certain conditions, 3.50 to 1.00 for the period in which such election is made and the next succeeding testing period and, thereafter, 3.25 to 1.00 for the next two succeeding testing periods) and (ii) the consolidated interest coverage ratio of the Company, determined as of the end of each fiscal quarter, to be at least 3.00 to 1.00. The Company was in compliance with all covenants as of December 31, 2023.
Annual principal payments required as of December 31, 2023 are as follows:
| | | | | |
(in millions) | |
2024 | $ | 14 | |
2025 | 44 | |
2026 | 19 | |
2027 | 21 | |
2028 | 724 | |
| |
Total payments | $ | 822 | |
Add: unamortized premiums, net of discount | (24) | |
Total | $ | 798 | |
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The Company’s long-term debt includes various covenants, none of which are expected to restrict future operations.
As of December 31, 2023, the estimated fair values of the Company’s Senior Notes, Term Loan A Facility and Term Loan B Facility (each as defined below) totaled $758 million, which is $35 million higher than carrying value for the same period. As of December 31, 2022, the estimated fair value of the Company’s senior unsecured notes totaled $23 million, which was $3 million lower than carrying value for the same period. Fair market values of the long-term debt are developed using observable values for similar debt instruments, which are considered Level 2 inputs as defined by ASC Topic 820. The carrying values of the Company’s other debt facilities approximate fair value. The fair value estimates do not necessarily reflect the values the Company could realize in the current markets.
NOTE 14 OTHER CURRENT AND NON-CURRENT LIABILITIES
Additional detail related to liabilities is presented in the table below:
| | | | | | | | | | | |
| December 31, |
(in millions) | 2023 | | 2022 |
Other current liabilities: | | | |
Customer related | $ | 109 | | | $ | 96 | |
Payroll and employee related | 92 | | | 81 | |
Income taxes payable | 39 | | | 28 | |
Product warranties (Note 12) | 30 | | | 32 | |
Accrued freight | 21 | | | 13 | |
Operating leases (Note 21) | 17 | | | 18 | |
Supplier related | 14 | | | 8 | |
Employee termination benefits (Note 3) | 9 | | | 16 | |
Other non-income taxes | 8 | | | 12 | |
Deferred engineering | 6 | | | 17 | |
Deferred income | 6 | | | 3 | |
Legal and professional fees | 6 | | | 8 | |
| | | |
Notes payable and accrued interest due to Former Parent | — | | | 99 | |
| | | |
| | | |
| | | |
| | | |
| | | |
Other | 63 | | | 53 | |
Total other current liabilities | $ | 420 | | | $ | 484 | |
| | | |
Other non-current liabilities: | | | |
Deferred income taxes (Note 6) | $ | 56 | | | $ | 46 | |
Operating leases (Note 21) | 49 | | | 69 | |
Product warranties (Note 12) | 26 | | | 28 | |
Deferred income | 7 | | | — | |
Uncertain tax positions | 15 | | | 37 | |
Due to Former Parent | — | | | 957 | |
Other | 12 | | | 19 | |
Total other non-current liabilities | $ | 165 | | | $ | 1,156 | |
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 15 FAIR VALUE MEASUREMENTS
ASC Topic 820 emphasizes that fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering market participant assumptions in fair value measurements, ASC Topic 820 establishes a fair value hierarchy, which prioritizes the inputs used in measuring fair values as follows:
Level 1:Observable inputs such as quoted prices for identical assets or liabilities in active markets;
Level 2:Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and
Level 3:Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.
Assets and liabilities measured at fair value are based on one or more of the following three valuation techniques noted in ASC Topic 820:
A.Market approach: Prices and other relevant information generated by market transactions involving identical or comparable assets, liabilities or a group of assets or liabilities, such as a business.
B.Cost approach: Amount that would be required to replace the service capacity of an asset (replacement cost).
C.Income approach: Techniques to convert future amounts to a single present amount based upon market expectations (including present value techniques, option-pricing and excess earnings models).
There were no assets and liabilities measured at fair value on a recurring basis as of December 31, 2023. The following table classifies assets and liabilities measured at fair value on a recurring basis as of December 31, 2022:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Basis of fair value measurements |
(in millions) | Balance at December 31, 2022 | | Quoted prices in active markets for identical items (Level 1) | | Significant other observable inputs (Level 2) | | Significant unobservable inputs (Level 3) | | Valuation technique |
Assets: | | | | | | | | | |
Foreign currency contracts | $ | 7 | | | $ | — | | | $ | 7 | | | $ | — | | | A |
Liabilities: | | | | | | | | | |
Foreign currency contracts | $ | (1) | | | $ | — | | | $ | (1) | | | $ | — | | | A |
The following tables classify the Company’s defined benefit plan assets measured at fair value on a recurring basis:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Basis of fair value measurements |
(in millions) | Balance at December 31, 2023 | | Quoted prices in active markets for identical items (Level 1) | | Significant other observable inputs (Level 2) | | Significant unobservable inputs (Level 3) | | Valuation technique | | Assets measured at NAV1 |
Fixed income securities | $ | 414 | | | $ | 103 | | | $ | — | | | $ | — | | | A | | $ | 311 | |
Equity securities | 147 | | | 128 | | | — | | | 11 | | | A, C | | 8 | |
Cash | 54 | | | 54 | | | — | | | — | | | A | | — | |
Real estate and other | 202 | | | 5 | | | — | | | 64 | | | A, C | | 133 | |
| $ | 817 | | | $ | 290 | | | $ | — | | | $ | 75 | | | | | $ | 452 | |
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Basis of fair value measurements |
(in millions) | Balance at December 31, 2022 | | Quoted prices in active markets for identical items (Level 1) | | Significant other observable inputs (Level 2) | | Significant unobservable inputs (Level 3) | | Valuation technique | | Assets measured at NAV1 |
Fixed income securities | $ | 365 | | | $ | 30 | | | $ | — | | | $ | — | | | A | | $ | 335 | |
Equity securities | 68 | | | 55 | | | — | | | — | | | A | | 13 | |
Cash | 137 | | | 137 | | | — | | | — | | | A | | — | |
Real estate and other | 218 | | | — | | | — | | | 46 | | | C | | 172 | |
| $ | 788 | | | $ | 222 | | | $ | — | | | $ | 46 | | | | | $ | 520 | |
_____________________________
1 Certain assets that are measured at fair value using the Net Asset Value (NAV) per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy. These amounts represent investments in commingled and managed funds that have underlying assets in fixed income securities, equity securities, and other assets.
The reconciliation of Level 3 defined benefit plans assets was as follows: | | | | | | | | | | | |
| Fair Value Measurements Using Significant Unobservable Inputs (Level 3) |
(in millions) | Real estate and other | | Equity |
Balance, January 1, 2022 | $ | 127 | | | $ | — | |
Purchases, sales and settlements | (93) | | | — | |
Realized gains | 3 | | | — | |
Unrealized gains on assets still held at the reporting date | 25 | | | — | |
Translation adjustment | (16) | | | — | |
Balance, December 31, 2022 | $ | 46 | | | $ | — | |
Purchases, sales and settlements | 19 | | | 10 | |
| | | |
Unrealized losses on assets still held at the reporting date | (4) | | | — | |
Translation adjustment | 3 | | | 1 | |
Balance, December 31, 2023 | $ | 64 | | | $ | 11 | |
The fair value of real estate properties is estimated using an appraisal provided by the administrator of the property or infrastructure investment. The fair value of equity securities is estimated using the mark-to-model method. Management believes these are appropriate methodologies to obtain the fair value of these assets.
Refer to Note 17, “Retirement Benefit Plans,” to the Consolidated Financial Statements for more detail surrounding the defined benefit plan’s asset investment policies and strategies, target allocation percentages and expected return on plan asset assumptions.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 16 FINANCIAL INSTRUMENTS
The Company’s financial instruments include cash and cash equivalents, marketable securities and accounts receivable. Due to the short-term nature of these instruments, their book value approximates their fair value. The Company’s financial instruments may include long-term debt, interest rate and cross-currency swaps, commodity derivative contracts and foreign currency derivative contracts. All derivative contracts are placed with counterparties that have an S&P, or equivalent, investment grade credit rating at the time of the contracts’ placement. An adjustment for non-performance risk is considered in the estimate of fair value in derivative assets based on the counterparty credit default swap (CDS) rate. When the Company is in a net derivative liability position, the non-performance risk adjustment is based on its CDS rate. At December 31, 2023 and 2022, the Company had no derivative contracts that contained credit-risk-related contingent features.
The Company, at times, may use certain commodity derivative contracts to protect against commodity price changes related to forecasted raw material and component purchases. The Company had no outstanding commodity contracts at December 31, 2023 and 2022.
The Company manages its interest rate risk by balancing its exposure to fixed and variable rates while attempting to optimize its interest costs. The Company, at times, selectively may use interest rate swaps to reduce risk associated with changes in interest rates (fair value hedges and cash flow hedges). At December 31, 2023 and 2022, the Company had no outstanding interest rate swaps or options.
The Company may use foreign currency forward and option contracts to protect against exchange rate movements for forecasted cash flows, including capital expenditures, purchases, operating expenses or sales transactions denominated in currencies other than the functional currency of the operating unit. In addition, the Company may use foreign currency derivative instruments to hedge exposure associated with its net investment in certain foreign operations (net investment hedges). Foreign currency derivative contracts require the Company, at a future date, to either buy or sell foreign currency in exchange for the operating units’ local currency. As of December 31, 2023, there were no outstanding currency derivative instruments. As of December 31, 2022, the United States dollar equivalent notional values of outstanding currency derivative instruments was $309 million. These amounts were primarily related to Euro and British Pound denominated hedging contracts.
At December 31, 2023 and 2022, the following amounts were recorded in the Consolidated Balance Sheets as being payable to or receivable from counterparties under ASC Topic 815, “Derivatives and Hedging”:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(in millions) | | Assets | | Liabilities |
Derivatives designated as hedging instruments Under Topic 815: | | Balance Sheet Location | | December 31, 2023 | | December 31, 2022 | | Balance Sheet Location | | December 31, 2023 | | December 31, 2022 |
Foreign currency | | Prepayments and other current assets | | $ | — | | | $ | 7 | | | Other current liabilities | | $ | — | | | $ | 1 | |
Effectiveness for cash flow hedges is assessed at the inception of the hedging relationship and quarterly, thereafter. Gains and losses arising from these contracts that are included in the assessment of effectiveness are deferred in accumulated other comprehensive income (loss) (AOCI) and reclassified into income as the underlying operating transactions are recognized. The realized gains or losses offset the hedged transaction and are recorded on the same line in the statement of operations. The initial value of any component excluded from the assessment of effectiveness is recognized in income using a systematic and rational method over the life of the hedging instrument. Any difference between the change in fair value of the excluded component and amounts recognized in income under that systematic and rational method are recognized in AOCI.
Effectiveness for net investment hedges is assessed at the inception of the hedging relationship and quarterly, thereafter. Gains and losses arising from these contracts that are included in the assessment of effectiveness are deferred into foreign currency translation adjustments and only released when the subsidiary being hedged is sold or substantially liquidated. The initial value of any component excluded from the assessment of effectiveness is recognized in income using a systematic and rational method over the life of the hedging instrument. Any difference
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
between the change in fair value of the excluded component and amounts recognized in income under that systematic and rational method is recognized in AOCI.
The table below shows deferred gains (losses) reported in AOCI as well as the amount expected to be reclassified to income in one year or less for designated net investment hedges. The amount expected to be reclassified to income in one year or less assumes no change in the current relationship of the hedged item at December 31, 2023 market rates.
| | | | | | | | | | | | | | | | | | | | |
(in millions) | | Deferred gain (loss) in AOCI at | | Gain (loss) expected to be reclassified to income in one year or less |
Contract Type | | December 31, 2023 | | December 31, 2022 | |
Foreign currency | | $ | (6) | | | $ | (4) | | | $ | — | |
Derivative instruments designated as hedging instruments as defined by ASC Topic 815 recognized in Other comprehensive income for the years ended December 31, 2023, 2022, and 2021 were a loss of $3 million, a gain of $5 million, and a loss of $2 million, respectively. No gains or losses were recorded in Net earnings for the periods presented.
The gains or losses recorded in income related to components excluded from the assessment of effectiveness for derivative instruments designated as cash flow hedges were immaterial for the periods presented.
Gains and (losses) on derivative instruments designated as net investment hedges were recognized in other comprehensive income (loss) during the periods presented below.
| | | | | | | | | | | | | | | | | | | | |
(in millions) | | Year Ended December 31, |
Net investment hedges | | 2023 | | 2022 | | 2021 |
Foreign currency | | $ | (2) | | | $ | 6 | | | $ | (9) | |
Derivatives not designated as hedging instruments are used to hedge remeasurement exposures of monetary assets and liabilities denominated in currencies other than the operating units' functional currency. These derivatives resulted in the following gains (losses) recorded in income:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
(in millions) | | | | Year Ended December 31, |
Contract Type | | Location | | 2023 | | 2022 | | 2021 |
Foreign Currency | | Cost of sales | | $ | 4 | | | $ | (1) | | | $ | 1 | |
Foreign Currency | | Selling, general and administrative expenses | | $ | (1) | | | $ | — | | | $ | — | |
NOTE 17 RETIREMENT BENEFIT PLANS
The Company sponsors various defined contribution savings plans, primarily in the U.S., that allow employees to contribute a portion of their pre-tax and/or after-tax income in accordance with plan specified guidelines. Under specified conditions, the Company will make contributions to the plans and/or match a percentage of the employee contributions up to certain limits.
Prior to the Spin-Off, certain of the Company’s employees participated in defined benefit pension plans sponsored in part by BorgWarner. The Company has recorded negligible expense for the years ended December 31, 2023, 2022 and 2021, to record its allocation of pension expense related to this plan. In connection with the completion of the Spin-Off, the Company was required to assume additional defined benefit plan liabilities, along with the associated deferred costs in Accumulated other comprehensive loss.
The Company has a number of defined benefit pension plans covering eligible salaried and hourly employees and their dependents. The defined pension benefits provided are primarily based on (1) years of service and (2) average compensation or a monthly retirement benefit amount. The Company provides defined benefit pension plans in
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
France, Germany, India, Japan, Mexico, Turkey, South Korea and the United Kingdom. The Company’s U.K. defined benefit plans are frozen, and no additional service cost is being accrued. The measurement date for all plans is December 31.
The following table summarizes the expenses (income) for the Company’s defined contribution and defined benefit pension plans:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
(in millions) | 2023 | | 2022 | | 2021 |
Defined contribution expense | $ | 14 | | | $ | 23 | | | $ | 21 | |
Defined benefit pension expense (income) | 5 | | | (30) | | | (35) | |
| | | | | |
Total | $ | 19 | | | $ | (7) | | | $ | (14) | |
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The following provides a roll forward of the plans’ benefit obligations, plan assets, funded status and recognition in the Consolidated Balance Sheets:
| | | | | | | | | | | |
| Pension Benefits |
| |
(in millions) | 2023 | | 2022 |
Change in projected benefit obligation: | | | |
Projected benefit obligation, January 1 | $ | 867 | | | $ | 1,520 | |
Service cost | 3 | | | 2 | |
Interest cost | 45 | | | 25 | |
| | | |
Plan amendments | — | | | (11) | |
Settlement and curtailment | (2) | | | (2) | |
Actuarial loss (gain) | 9 | | | (492) | |
Currency translation | 42 | | | (149) | |
Other | 1 | | | 21 | |
Spin-Off | 33 | | | — | |
Benefits paid | (48) | | | (47) | |
Projected benefit obligation, December 311 | $ | 950 | | | $ | 867 | |
Change in plan assets: | | | |
Fair value of plan assets, January 1 | $ | 788 | | | $ | 1,489 | |
Actual return on plan assets | 19 | | | (510) | |
Employer contribution | 5 | | | 3 | |
| | | |
Settlements | (2) | | | (2) | |
Currency translation | 41 | | | (145) | |
| | | |
Spin-Off | 14 | | | — | |
Benefits paid | (48) | | | (47) | |
Fair value of plan assets, December 31 | $ | 817 | | | $ | 788 | |
Funded status | $ | (133) | | | $ | (79) | |
Amounts in the Consolidated Balance Sheets consist of: | | | |
Non-current assets | $ | — | | | $ | 1 | |
Current liabilities | (2) | | | (1) | |
Non-current liabilities | (131) | | | (79) | |
Net amount | $ | (133) | | | $ | (79) | |
Amounts in accumulated other comprehensive loss consist of: | | | |
Net actuarial loss | $ | 40 | | | $ | 1 | |
Net prior service credit | (10) | | | (10) | |
Net amount | $ | 30 | | | $ | (9) | |
| | | |
Total accumulated benefit obligation for all plans | $ | 932 | | | $ | 854 | |
_____________________________
1 The increase in the projected benefit obligation was primarily due to currency translation during the period as well as liabilities assumed as part of the Spin-Off.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The funded status of pension plans with accumulated benefit obligations in excess of plan assets is as follows: | | | | | | | | | | | |
| December 31, |
(in millions) | 2023 | | 2022 |
Accumulated benefit obligation | $ | (929) | | | $ | (852) | |
Plan assets | 813 | | | 784 | |
Deficiency | $ | (116) | | | $ | (68) | |
Pension deficiency by country: | | | |
United Kingdom | (71) | | | (38) | |
France | (17) | | | (15) | |
Mexico | (17) | | | (4) | |
Other | (11) | | | (11) | |
Total pension deficiency | $ | (116) | | | $ | (68) | |
The funded status of pension plans with projected benefit obligations in excess of plan assets is as follows: | | | | | | | | | | | |
| December 31, |
(in millions) | 2023 | | 2022 |
Projected benefit obligation | $ | (947) | | | $ | (863) | |
Plan assets | 813 | | | 784 | |
Deficiency | $ | (134) | | | $ | (79) | |
Pension deficiency by country: | | | |
| | | |
United Kingdom | (71) | | | (38) | |
France | (21) | | | (19) | |
Mexico | (25) | | | (5) | |
Other | (17) | | | (17) | |
Total pension deficiency | $ | (134) | | | $ | (79) | |
The weighted average asset allocations of the Company’s funded pension plans and target allocations by asset category are as follows:
| | | | | | | | | | | | | | | | | |
| December 31, | | Target Allocation |
| 2023 | | 2022 | |
Real estate, cash and other | 42 | % | | 45 | % | | 20% - 60% |
Fixed income securities | 42 | % | | 46 | % | | 30% - 50% |
Equity securities | 16 | % | | 9 | % | | 10% - 30% |
| 100 | % | | 100 | % | | |
The Company’s investment strategy is to maintain actual asset weightings within a preset range of target allocations. The Company believes these ranges represent an appropriate risk profile for the planned benefit payments of the plans based on the timing of the estimated benefit payments. In each asset category, separate portfolios are maintained for additional diversification. Investment managers are retained in each asset category to manage each portfolio against its benchmark. Each investment manager has appropriate investment guidelines. In addition, the entire portfolio is evaluated against a relevant peer group. The defined benefit pension plans did not hold any Company securities as investments as of December 31, 2023 and 2022. A portion of pension assets is invested in common and commingled trusts.
The Company expects to contribute a total of $4 million to $8 million into its defined benefit pension plans during 2024. Of the $4 million to $8 million in projected 2024 contributions, $2 million are contractually obligated, while any remaining payments would be discretionary.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Refer to Note 15, “Fair Value Measurements,” to the Consolidated Financial Statements for more detail surrounding the fair value of each major category of plan assets, as well as the inputs and valuation techniques used to develop the fair value measurements of the plans’ assets at December 31, 2023 and 2022.
See the table below for a breakout of net periodic benefit (income) cost:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
(in millions) | 2023 | | 2022 | | 2021 |
Service cost | $ | 3 | | | $ | 2 | | | $ | 4 | |
Interest cost | 45 | | | 25 | | | 20 | |
Expected return on plan assets | (43) | | | (57) | | | (58) | |
| | | | | |
Amortization of unrecognized gain | (2) | | | — | | | — | |
Settlements, curtailments and other | 2 | | | — | | | (1) | |
Net periodic cost (income) | $ | 5 | | | $ | (30) | | | $ | (35) | |
The components of net periodic benefit cost other than the service cost component are included in Other postretirement income in the Consolidated Statements of Operations.
The Company’s weighted average assumptions used to determine the benefit obligations for its defined benefit pension plans were as follows:
| | | | | | | | | | | |
| December 31, |
(percent) | 2023 | | 2022 |
Discount rate1 | 4.98 | % | | 5.00 | % |
Rate of compensation increase | 5.49 | % | | 5.08 | % |
________________
1 Includes 4.62% and 4.93% for the U.K. pension plans for December 31, 2023 and 2022, respectively.
The Company’s weighted average assumptions used to determine the net periodic benefit cost(income) for its defined benefit pension plans were as follows:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
(percent) | 2023 | | 2022 | | 2021 |
Discount rate1 | 5.19 | % | | 2.07 | % | | 1.41 | % |
Effective interest rate on benefit obligation | 5.24 | % | | 1.94 | % | | 1.20 | % |
Expected long-term rate of return on assets2 | 5.53 | % | | 4.22 | % | | 3.97 | % |
Average rate of increase in compensation | 5.03 | % | | 5.05 | % | | 3.08 | % |
________________
1 Includes 4.93%, 1.81% and 1.34% for the U.K. pension plans for December 31, 2023, 2022 and 2021, respectively.
2 Includes 5.50%, 4.18% and 3.95% for the U.K. pension plans for December 31, 2023, 2022 and 2021, respectively.
The Company's approach to establishing the discount rate is based upon the market yields of high-quality corporate bonds, with appropriate consideration of each plan's defined benefit payment terms and duration of the liabilities. In determining the discount rate, the Company utilizes a full-yield approach in the estimation of service and interest components by applying the specific spot rates along the yield curve used in the determination of the benefit obligation to the relevant projected cash flows.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The Company determines its expected return on plan asset assumptions by evaluating estimates of future market returns and the plans’ asset allocation. The Company also considers the impact of active management of the plans’ invested assets.
The estimated future benefit payments for the pension benefits are as follows:
| | | | | | | | |
(in millions) | | |
Year | | Pension Benefits |
2024 | | $ | 56 | |
2025 | | 51 | |
2026 | | 52 | |
2027 | | 55 | |
2028 | | 57 | |
2029-2033 | | 315 | |
NOTE 18 STOCK-BASED COMPENSATION
The Company has granted restricted common stock and restricted stock units (collectively, “restricted stock”) as long-term incentive awards to employees and non-employee directors under the PHINIA Inc. 2023 Stock Incentive Plan (2023 Plan). The Company’s Board of Directors adopted the 2023 Plan in July 2023. The 2023 Plan authorizes the issuance of a total of 4.7 million shares. Approximately 4.4 million shares were available for future issuance as of December 31, 2023.
BorgWarner granted restricted stock and performance share units as long-term incentive awards to employees and non-employee directors under the BorgWarner Inc. 2018 Stock Incentive Plan (2018 Plan). BorgWarner’s Board of Directors adopted the 2018 Plan in February 2018, and the BorgWarner stockholders approved the 2018 Plan at the annual meeting of stockholders on April 25, 2018. As discussed further below, outstanding awards under the 2018 Plan were replaced with PHINIA equity awards.
Stock-based compensation expense within the consolidated financial statements for periods prior to the Spin-Off was allocated to PHINIA based on the awards and terms previously granted to PHINIA employees while part of BorgWarner and includes the cost of PHINIA employees who participated in the 2018 Plan, as well as an allocated portion of the cost of the BorgWarner corporate employee awards.
In connection with the Spin-Off, outstanding equity awards to executives and non-employee directors under the 2018 Plan were replaced with PHINIA equity awards using a formula designed to maintain the economic value of the awards immediately before and after the Spin-Off. Accordingly, the number of restricted stock underlying each unvested award outstanding as of the date of the Spin-Off was multiplied by a factor of 1.74, which resulted in no increase in the intrinsic value of awards outstanding. The replaced restricted stock awards continue to vest in accordance with their original vesting period. These replacement awards did not result in additional compensation expense to the Company.
Restricted Stock: The value of restricted stock is determined by the market value of the Company’s common stock at the date of grant. In 2023, BorgWarner granted restricted stock in the amount of approximately 200 thousand shares to employees and PHINIA granted restricted stock in the amount of approximately 250 thousand shares and 100 thousand shares to employees and non-employee directors, respectively. The value of the awards is recognized as compensation expense ratably over the restriction periods, generally two or three years for employees and one year for non-employee directors. As of December 31, 2023, there was $17 million of unrecognized compensation expense related to restricted stock that will be recognized over a weighted average period of approximately 2.0 years.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Restricted stock compensation expense recorded in the Consolidated Statements of Operations is as follows:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
(in millions, except per share data) | 2023 | | 2022 | | 2021 |
Restricted stock compensation expense | $ | 10 | | | $ | 9 | | | $ | 10 | |
Restricted stock compensation expense, net of tax | $ | 8 | | | $ | 7 | | | $ | 8 | |
A summary of the status of the Company’s nonvested restricted stock for employees and non-employee directors is as follows:
| | | | | | | | | | | |
| Shares subject to restriction (thousands) | | Weighted average grant date fair value |
Nonvested at January 1, 2021 | 217 | | | $ | 39.20 | |
Granted | 177 | | | $ | 43.65 | |
Vested | (67) | | | $ | 36.64 | |
Forfeited | (37) | | | $ | 46.74 | |
| | | |
Nonvested at December 31, 2021 | 290 | | | $ | 41.53 | |
Granted | 143 | | | $ | 44.42 | |
Vested | (63) | | | $ | 38.75 | |
Forfeited | (40) | | | $ | 44.89 | |
Nonvested at December 31, 2022 | 330 | | | $ | 42.91 | |
Granted | 505 | | | $ | 33.99 | |
Vested | (222) | | | $ | 34.03 | |
Forfeited | (49) | | | $ | 45.61 | |
Converted1 | 513 | | | |
Nonvested at December 31, 20231 | 1,077 | | | $ | 20.01 | |
1 Reflects the replacement of outstanding equity awards to executives under the Former Parent Plan with PHINIA equity awards in conjunction with the Spin-Off. Outstanding equity awards to executives were multiplied by the conversion rate of 1.74.
Performance share units: BorgWarner granted performance share units to members of senior management that were scheduled to vest at the end of three-year periods based on the metrics outlined below. These awards allowed for a payout between 0% and 200% of the target performance share units based on BorgWarner’s performance against the metrics in the table below. At Spin-Off, these performance share units were replaced with PHINIA restricted stock unit awards (RSUs), based on their target performance, as agreed upon by the BorgWarner Compensation Committee considering performance through the date of the Spin-Off, and then multiplied by the conversion rate of 1.74, as discussed above.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Metric | | 2019 - 2021 Former Parent Grants | | 2020 - 2022 Former Parent Grants | | 2021 - 2023 Former Parent Grants | | 2022 - 2024 Former Parent Grants | | 2023 - 2025 Former Parent Grants |
Total stockholder return1 | | 50 | % | | 33 | % | | 25 | % | | 25 | % | | 25 | % |
Relative revenue growth2 | | 50 | % | | 33 | % | | N/A | | N/A | | N/A |
Adjusted earnings per share3 | | N/A | | 33 | % | | N/A | | N/A | | N/A |
eProducts revenue mix4 | | N/A | | N/A | | 50 | % | | 25 | % | | 25 | % |
Cumulative free cash flow5 | | N/A | | N/A | | 25 | % | | 25 | % | | 25 | % |
eProducts revenue6 | | N/A | | N/A | | N/A | | 25 | % | | 25 | % |
________________1 Total stockholder return was measured based on BorgWarner’s market performance in terms of total shareholder return relative to a peer group of automotive companies.
2 Relative revenue growth was measured based on BorgWarner’s performance in terms of revenue growth relative to the vehicle market over three-year performance period.
3 Adjusted earnings per share was based on BorgWarner’s earnings per share adjusted for certain one-time items and non-operating gains and losses against a pre-defined target measured in the third year of the performance period.
4 eProducts revenue mix was based on BorgWarner’s total revenue derived from eProducts in relation to its total proforma revenue in the third year of the performance period.
5 Cumulative free cash flow was based on BorgWarner’s performance in terms of its operating cash flow, less capital expenditures, over the three-year performance period.
6 eProducts revenue was based on the amount of BorgWarner’s total revenue derived from eProducts in the third year of the performance period.
The amounts expensed and common stock issued for performance share units for the years ended December 31, 2023, 2022 and 2021 were as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| 2023 | | 2022 | | 2021 |
| Expense (in millions) | Number of shares issued (in thousands) | | Expense (in millions) | Number of shares issued (in thousands) | | Expense (in millions) | Number of shares issued (in thousands) |
Total Stockholder Return | $ | — | | 8 | | | $ | 1 | | — | | | $ | — | | — | |
Other Performance-Based | 1 | | 23 | | | 1 | | 21 | | | 1 | | 10 | |
Total | $ | 1 | | 31 | | | $ | 2 | | 21 | | | $ | 1 | | 10 | |
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
A summary of the status of the Company’s nonvested performance share units for the years ended December 31, 2023, 2022 and 2021 were as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| Total Stockholder Return | | Other Performance-Based |
| Number of shares (in thousands) | | Weighted average grant date fair value | | Number of shares (in thousands) | | Weighted average grant date fair value |
Nonvested at January 1, 2021 | 26 | | | $ | 48.28 | | | 54 | | | $ | 40.95 | |
Granted | 12 | | | $ | 70.39 | | | 37 | | | $ | 45.30 | |
Vested | — | | | $ | — | | | (10) | | | $ | 52.64 | |
Forfeited | (7) | | | $ | 73.11 | | | — | | | $ | — | |
Nonvested at December 31, 2021 | 31 | | | $ | 51.65 | | | 81 | | | $ | 41.43 | |
Granted | 7 | | | $ | 66.89 | | | 21 | | | $ | 44.62 | |
Vested | — | | | $ | — | | | (21) | | | $ | 41.92 | |
Forfeited | (15) | | | $ | 54.59 | | | (13) | | | $ | 45.30 | |
Nonvested at December 31, 2022 | 23 | | | $ | 54.42 | | | 68 | | | $ | 41.53 | |
Granted | 7 | | | $ | 79.71 | | | 22 | | | $ | 48.19 | |
Vested | (10) | | | $ | 28.55 | | | (20) | | | $ | 34.69 | |
| | | | | | | |
Converted1 | (20) | | | | | (70) | | | |
Nonvested at December 31, 20231 | — | | | | | — | | | |
________________1 Reflects the conversion of outstanding equity awards to executives under the Former Parent Plan into PHINIA equity awards in conjunction with the Spin-Off.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 19 ACCUMULATED OTHER COMPREHENSIVE LOSS
The following table summarizes the activity within accumulated other comprehensive loss:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
(in millions) | | Foreign currency translation adjustments | | Defined benefit pension plans | | Hedge instruments | | Total |
Beginning Balance, January 1, 2021 | | $ | 45 | | | $ | (69) | | | $ | — | | | $ | (24) | |
| | | | | | | | |
Comprehensive (loss) income before reclassifications | | (40) | | | 176 | | | (2) | | | 134 | |
Income taxes associated with comprehensive (loss) income before reclassifications | | — | | | (48) | | | — | | | (48) | |
| | | | | | | | |
| | | | | | | | |
Ending Balance December 31, 2021 | | $ | 5 | | | $ | 59 | | | $ | (2) | | | $ | 62 | |
Comprehensive (loss) income before reclassifications | | (90) | | | (85) | | | 5 | | | (170) | |
Income taxes associated with comprehensive (loss) income before reclassifications | | — | | | 20 | | | — | | | 20 | |
| | | | | | | | |
| | | | | | | | |
Ending Balance December 31, 2022 | | $ | (85) | | | $ | (6) | | | $ | 3 | | | $ | (88) | |
Comprehensive (loss) income before reclassifications1 | | (13) | | | (40) | | | — | | | (53) | |
Income taxes associated with comprehensive (loss) income before reclassifications | | — | | | 11 | | | — | | | 11 | |
Reclassification from accumulated other comprehensive (loss) income | | — | | | 2 | | | (3) | | | (1) | |
| | | | | | | | |
Ending Balance December 31, 2023 | | $ | (98) | | | $ | (33) | | | $ | — | | | $ | (131) | |
_____________________________
1 The increase in the defined benefit postretirement plans comprehensive income before reclassifications is primarily due to actuarial gains during the period. Refer to Note 17 “Retirement Benefit Plans,” for more information.
NOTE 20 CONTINGENCIES
In the course of its business, the Company is party to various commercial and legal claims, actions and complaints, including matters involving warranty claims, intellectual property claims, governmental investigations and related proceedings, including relating to alleged or actual violations of vehicle emissions standards, general liability and various other risks. It is not possible to predict with certainty whether or not the Company will ultimately be successful in any of these commercial and legal matters or, if not, what the impact might be. The Company’s management does not believe that adverse outcomes in any of these commercial and legal claims, actions and complaints are reasonably likely to have a material adverse effect on the Company’s results of operations, financial position or cash flows. An adverse outcome could, nonetheless, be material to the results of operations or cash flows.
NOTE 21 LEASES AND COMMITMENTS
The Company’s lease agreements primarily consist of real estate property, such as manufacturing facilities, warehouses and office buildings, in addition to personal property, such as vehicles, manufacturing and information technology equipment. The Company determines whether a contract is or contains a lease at contract inception. The majority of the Company's lease arrangements are comprised of fixed payments, and a limited number of these arrangements include a variable payment component based on certain index fluctuations. As of December 31, 2023, a significant portion of the Company’s leases were classified as operating leases.
Generally, the Company’s operating leases have renewal options that extend the lease terms, and some include options to terminate the agreement or purchase the leased asset. The amortizable life of these assets is the lesser of its useful life or the lease term, including renewal periods reasonably assured of being exercised at lease inception.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
All leases with an initial term of 12 months or less without an option to extend or purchase the underlying asset that the Company is reasonably certain to exercise (short-term leases) are not recorded on the Consolidated Balance Sheet, and lease expense is recognized on a straight-line basis over the lease term.
The following table presents the lease assets and lease liabilities as of December 31, 2023 and 2022:
| | | | | | | | | | | | | | |
| | December 31, |
(in millions) | | 2023 | | 2022 |
Assets | Balance Sheet Location | | | |
Operating leases | Other non-current assets | $ | 63 | | | $ | 82 | |
| | | | |
Total lease assets | | $ | 63 | | | $ | 82 | |
| | | | |
Liabilities | | | | |
Current | | | | |
Operating leases | Other current liabilities | $ | 17 | | | $ | 18 | |
| | | | |
Non-current | | | | |
Operating leases | Other non-current liabilities | 49 | | | 69 | |
| | | | |
Total lease liabilities | | $ | 66 | | | $ | 87 | |
The following table presents lease obligations arising from obtaining leased assets for the years ended December 31, 2023 and 2022:
| | | | | | | | | | | | | | | | | |
| December 31, |
(in millions) | 2023 | | 2022 | | 2021 |
Operating leases | $ | 12 | | | $ | 15 | | | $ | 2 | |
| | | | | |
Total lease obligations | $ | 12 | | | $ | 15 | | | $ | 2 | |
The following table presents the maturity of lease liabilities as of December 31, 2023:
| | | | | | | |
(in millions) | Operating leases | | |
2024 | $ | 19 | | | |
2025 | 17 | | | |
2026 | 15 | | | |
2027 | 13 | | | |
2028 | 4 | | | |
After 2028 | 2 | | | |
Total (undiscounted) lease payments | $ | 70 | | | |
Less: Imputed interest | 4 | | | |
Present value of lease liabilities | $ | 66 | | | |
In the years ended December 31, 2023, 2022 and 2021, the Company recorded operating lease expense of $15 million, $18 million and $27 million, respectively.
In the years ended December 31, 2023, 2022 and 2021, the operating cash flows for operating leases were $20 million, $21 million and $24 million, respectively.
In the years ended December 31, 2023, 2022 and 2021, the Company recorded short-term lease costs of $1 million, $4 million and $5 million, respectively.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Finance lease liabilities and costs were immaterial for the periods presented.
ASC Topic 842 requires that the rate implicit in the lease be used if readily determinable. Generally, implicit rates are not readily determinable in the Company’s agreements, so the incremental borrowing rate is used instead for such lease arrangements. The incremental borrowing rates are determined using rates specific to the term of the lease, economic environments where lease activity is concentrated, value of lease portfolio, and assuming full collateralization of the loans. The following table presents the terms and discount rates: | | | | | | | | | | | |
| December 31, |
| 2023 | | 2022 |
Weighted average remaining lease term (years) | | | |
Operating leases | 4 | | 5 |
| | | |
Weighted average discount rate | | | |
Operating leases | 3.0 | % | | 1.9 | % |
| | | |
NOTE 22 EARNINGS PER SHARE
The Company presents both basic and diluted earnings per share of common stock (EPS) amounts. Basic EPS is calculated by dividing net earnings by the weighted average shares of common stock outstanding during the reporting period. Diluted EPS is calculated by dividing net earnings by the weighted average shares of common stock and common stock equivalents outstanding during the reporting period.
For periods prior to July 3, 2023, the denominator for basic and diluted earnings per share was calculated using the 47.0 million PHINIA ordinary shares outstanding immediately following the Spin-Off. The same number of shares was used to calculate basic and diluted earnings per share in those periods since no PHINIA equity awards were outstanding prior to the Spin-Off.
The dilutive impact of stock-based compensation is calculated using the treasury stock method. The treasury stock method assumes that the Company uses the assumed proceeds from the exercise of awards to repurchase common stock at the average market price during the period. The assumed proceeds under the treasury stock method include the purchase price that the grantee will pay in the future and compensation cost for future service that the Company has not yet recognized.
The following table reconciles the numerators and denominators used to calculate basic and diluted earnings per share of common stock:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
(in millions except share and per share amounts) | 2023 | | 2022 | | 2021 |
Basic earnings per share: | | | | | |
Net earnings attributable to PHINIA Inc. | $ | 102 | | | $ | 262 | | | $ | 152 | |
Weighted average shares of common stock outstanding | 46.9 | | 47.0 | | | 47.0 | |
Basic earnings per share of common stock | $ | 2.17 | | | $ | 5.57 | | | $ | 3.23 | |
| | | | | |
Diluted earnings per share: | | | | | |
Net earnings attributable to PHINIA Inc. | $ | 102 | | | $ | 262 | | | $ | 152 | |
Weighted average shares of common stock outstanding | 46.9 | | 47.0 | | | 47.0 | |
Effect of stock-based compensation | 0.1 | | — | | | — | |
Weighted average shares of common stock outstanding including dilutive shares | 47.0 | | 47.0 | | | 47.0 | |
Diluted earnings per share of common stock | $ | 2.17 | | | $ | 5.57 | | | $ | 3.23 | |
| | | | | |
| | | | | |
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 23 RELATED PARTY
Pursuant to the Spin-Off, the Former Parent ceased to be a related party to PHINIA and accordingly, no related party transactions or balances have been reported subsequent to July 3, 2023. In connection with the Spin-Off, we entered into a number of agreements with the Former Parent to govern the Spin-Off and provide a framework for the relationship between the parties going forward, including a Transition Services Agreement, Tax Matters Agreement, and certain Contract Manufacturing Agreements.
The following discussion summarizes activity between the Company and the Former Parent that occurred prior to the completion of the Spin-Off.
Allocation of General Corporate and Other Expenses
The Consolidated Statements of Operations include expenses for certain centralized functions and other programs provided and administered by the Former Parent that were charged directly to the Company prior to the Spin-Off. In addition, for purposes of preparing the financial statements on a carve-out basis, a portion of the Former Parent’s total corporate expenses was allocated to the Company. Similarly, certain centralized expenses incurred by the Company prior to the Spin-Off on behalf of subsidiaries of the Former Parent had been allocated to the Former Parent. See Note 1, “Summary of Significant Accounting Policies,” for a discussion of the methodology used to allocate corporate expenses for purposes of preparing these financial statements on a carve-out basis for periods prior to July 3, 2023.
Net corporate allocation expenses, primarily related to separation and transaction costs, in the year ended December 31, 2023 totaled $89 million, all of which were incurred prior to the Spin-Off. For the years ended December 31, 2022 and 2021, net corporate allocation expenses totaled $118 million and $84 million, respectively. These expenses were primarily included in Selling, general and administrative expenses and Other operating expense (income), net in the Consolidated Statements of Operations.
Royalty Income from Former Parent and R&D Income from Former Parent
The Company participated in royalty arrangements and provided applications testing and other R&D services to the Former Parent prior to the Spin-Off. See Note 5, “Other Operating Expense (Income), Net” for additional information.
Due from Former Parent
In the Consolidated Balance Sheets, the Company presents $142 million within Accounts receivable and $208 million within Investments and long-term receivables as of December 31, 2022. These amounts for December 31, 2022 were previously presented as Due from Former Parent, current and Due from Former Parent, non-current, respectively.
Due to Former Parent
In the Consolidated Balance Sheets, the Company presents $186 million within Accounts payable and $99 million within Other current liabilities as of December 31, 2022. These amounts for December 31, 2022 were previously presented as Due to Former Parent, current. In addition, the Company presents $957 million within Other non-current liabilities as of December 31, 2022. These amounts for December 31, 2022 were previously presented as Due to Former Parent, non-current.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Net Transfers from (to) Former Parent
Net transfers from (to) Former Parent are included within Former Parent investment in the Consolidated Statements of Changes in Equity. The components of the transfers from (to) Former Parent are as follows:
| | | | | | | | | | | | | | | | | | | | | |
| | | Year Ended December 31, |
(in millions) | | | | | 2023 | | 2022 | | 2021 |
General financing activities | | | | | $ | (63) | | | $ | (175) | | | $ | (117) | |
Cash pooling and other equity settled balances with Former Parent | | | | | (64) | | | (110) | | | 70 | |
Related-party notes converted to equity | | | | | 260 | | | — | | | 798 | |
Corporate allocations | | | | | 89 | | | 118 | | | 84 | |
Research and development income from Former Parent | | | | | (2) | | | (11) | | | (10) | |
Total net transfers from Former Parent | | | | | $ | 220 | | | $ | (178) | | | $ | 825 | |
Exclude non-cash items: | | | | | | | | | |
Stock-based compensation | | | | | $ | (4) | | | $ | (11) | | | $ | (11) | |
Other non-cash activities with Former Parent, net | | | | | (16) | | | (33) | | | (15) | |
Related-party notes converted to equity | | | | | (260) | | | — | | | (798) | |
Cash pooling and intercompany financing activities with Former Parent, net | | | | | 55 | | | 18 | | | 7 | |
Total net transfers to Former Parent per Consolidated Statements of Cash Flow | | | | | $ | (5) | | | $ | (204) | | | $ | 8 | |
NOTE 24 REPORTABLE SEGMENTS AND RELATED INFORMATION
The Company’s business is comprised of two reportable segments, which are further described below. These segments are strategic business groups, which are managed separately as each represents a specific grouping of related automotive components and systems.
•Fuel Systems. This segment provides advanced fuel injection systems, fuel delivery modules, canisters, sensors, electronic control modules and associated software. Our highly engineered fuel injection systems portfolio includes pumps, injectors, fuel rail assemblies, engine control modules, and complete systems, including software and calibration services, that reduce emissions and improve fuel economy for traditional and hybrid applications.
•Aftermarket. Through this segment, the Company sells products to independent aftermarket customers and OES customers. Its product portfolio includes a wide range of products as well as maintenance, test equipment and vehicle diagnostics solutions. The Aftermarket segment also includes sales of starters and alternators to OEMs.
Segment Adjusted Operating Income (AOI) is the measure of segment income or loss used by the Company. Segment AOI is comprised of segment operating income adjusted for restructuring, separation and transaction costs, intangible asset amortization expense, impairment charges, other net expenses and other items not reflective of ongoing operating income or loss. The Company believes Segment AOI is most reflective of the operational profitability or loss of its reportable segments. Segment AOI excludes certain corporate costs, which primarily represent corporate expenses not directly attributable to the individual segments.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The following tables show segment information and Segment AOI for the Company’s reportable segments:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
2023 Segment information | | | | | | | | | | | |
| Net sales | | Year-end assets | | Depreciation/ amortization | | Long-lived asset expenditures1 |
(in millions) | Customers | | Inter-segment | | Net | | | |
Fuel Systems | $ | 2,177 | | | $ | 230 | | | $ | 2,407 | | | $ | 2,207 | | | $ | 141 | | | $ | 136 | |
Aftermarket | 1,323 | | | 6 | | | 1,329 | | | 1,364 | | | 28 | | | 13 | |
Inter-segment eliminations | — | | | (236) | | | (236) | | | — | | | — | | | — | |
Total | 3,500 | | | — | | | 3,500 | | | 3,571 | | | 169 | | | 149 | |
Corporate2 | — | | | — | | | — | | | 470 | | | 1 | | | 1 | |
Consolidated | $ | 3,500 | | | $ | — | | | $ | 3,500 | | | $ | 4,041 | | | $ | 170 | | | $ | 150 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
2022 Segment information | | | | | | | | | | | |
| Net sales | | Year-end assets | | Depreciation/ amortization | | Long-lived asset expenditures1 |
(in millions) | Customers | | Inter-segment | | Net | | | |
Fuel Systems | $ | 2,072 | | | $ | 221 | | | $ | 2,293 | | | $ | 2,314 | | | $ | 142 | | | $ | 91 | |
Aftermarket | 1,276 | | | 8 | | | 1,284 | | | 1,348 | | | 27 | | | 16 | |
Inter-segment eliminations | — | | | (229) | | | (229) | | | — | | | — | | | — | |
Total | 3,348 | | | — | | | 3,348 | | | 3,662 | | | 169 | | | 107 | |
Corporate2 | — | | | — | | | — | | | 412 | | | 1 | | | — | |
Consolidated | $ | 3,348 | | | $ | — | | | $ | 3,348 | | | $ | 4,074 | | | $ | 170 | | | $ | 107 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
2021 Segment information | | | | | | | | | | | |
| Net sales | | Year-end assets | | Depreciation/ amortization | | Long-lived asset expenditures1 |
(in millions) | Customers | | Inter-segment | | Net | | | |
Fuel Systems | $ | 2,016 | | | $ | 217 | | | $ | 2,233 | | | $ | 2,422 | | | $ | 172 | | | $ | 140 | |
Aftermarket | 1,211 | | | 7 | | | 1,218 | | | 1,282 | | | 29 | | | 6 | |
Inter-segment eliminations | — | | | (224) | | | (224) | | | — | | | — | | | — | |
Total | 3,227 | | | — | | | 3,227 | | | 3,704 | | | 201 | | | 146 | |
Corporate2 | — | | | — | | | — | | | 478 | | | 3 | | | — | |
Consolidated | $ | 3,227 | | | $ | — | | | $ | 3,227 | | | $ | 4,182 | | | $ | 204 | | | $ | 146 | |
_______________
| | |
1 Long-lived asset expenditures include capital expenditures and tooling outlays. |
2 Corporate assets include cash and cash equivalents, investments and long-term receivables, and deferred income taxes. |
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Segment AOI | | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
(in millions) | 2023 | | 2022 | | 2021 |
Fuel Systems | $ | 215 | | | $ | 252 | | | $ | 227 | |
Aftermarket | 196 | | | 191 | | | 149 | |
Segment AOI | 411 | | | 443 | | | 376 | |
Corporate, including stock-based compensation | 64 | | | 79 | | | 116 | |
Royalty income from Former Parent | (17) | | | (31) | | | (22) | |
Intangible asset amortization expense | 28 | | | 28 | | | 29 | |
Separation and transaction costs | 80 | | | 31 | | | 7 | |
Restructuring expense (Note 3) | 12 | | | 11 | | | 55 | |
Asset impairments, write offs and lease modifications | — | | | 5 | | | 17 | |
Other non-comparable items | 3 | | | 2 | | | — | |
Equity in affiliates’ earnings, net of tax | (10) | | | (11) | | | (7) | |
Interest expense | 56 | | | 20 | | | 35 | |
Interest income | (13) | | | (6) | | | (1) | |
Other postretirement expense (income) | 2 | | | (32) | | | (39) | |
Earnings before income taxes and noncontrolling interest | 206 | | | 347 | | | 186 | |
Provision for income taxes | 104 | | | 85 | | | 33 | |
Net earnings | 102 | | | 262 | | | 153 | |
Net earnings attributable to the noncontrolling interest, net of tax | — | | | — | | | 1 | |
Net earnings attributable to PHINIA Inc. | $ | 102 | | | $ | 262 | | | $ | 152 | |
Geographic Information
During the years ended December 31, 2023, 2022 and 2021, approximately 71%, 73% and 78% of the Company’s consolidated net sales were outside the U.S., respectively, attributing sales to the location of production rather than the location of the customer. Outside the United States, no countries other than those presented below exceeded 5% of consolidated net sales during the years ended December 31, 2023, 2022, and 2021. The Company’s investments in equity securities are excluded from the definition of long-lived assets, as are goodwill and certain other non-current assets.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Net sales | | Long-lived assets |
(in millions) | 2023 | | 2022 | | 2021 | | 2023 | | 2022 | | 2021 |
United States | $ | 1,032 | | | $ | 916 | | | $ | 707 | | | $ | 138 | | | $ | 154 | | | $ | 144 | |
Europe: | | | | | | | | | | | |
United Kingdom | 712 | | | 650 | | | 653 | | | 175 | | | 169 | | | 181 | |
Romania | 238 | | | 219 | | | 256 | | | 139 | | | 136 | | | 143 | |
France | 139 | | | 156 | | | 207 | | | 59 | | | 60 | | | 74 | |
Poland | 180 | | | 156 | | | 171 | | | 55 | | | 51 | | | 49 | |
| | | | | | | | | | | |
Other Europe | 156 | | | 124 | | | 142 | | | 45 | | | 43 | | | 51 | |
Total Europe | 1,425 | | | 1,305 | | | 1,429 | | | 473 | | | 459 | | | 498 | |
China | 503 | | | 606 | | | 642 | | | 203 | | | 224 | | | 267 | |
Mexico | 282 | | | 287 | | | 244 | | | 53 | | | 38 | | | 37 | |
Other foreign | 258 | | | 234 | | | 205 | | | 54 | | | 49 | | | 44 | |
Total | $ | 3,500 | | | $ | 3,348 | | | $ | 3,227 | | | $ | 921 | | | $ | 924 | | | $ | 990 | |
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Sales to Major Customers
Consolidated net sales to General Motors Company (including its subsidiaries) were approximately 16% and 12% for the years ended December 31, 2023 and 2022, respectively. Such sales consisted of a variety of products to a variety of customer locations and regions. No other single customer accounted for more than 10% of consolidated net sales in any of the years presented.
Sales by Product Line
Sales of products for commercial vehicle and industrial applications represented approximately 25%, 27% and 23% of consolidated net sales for the years ended December 31, 2023, 2022 and 2021, respectively. Sales of products for light vehicles represented approximately 44%, 46% and 46% of consolidated net sales for the years ended December 31, 2023, 2022 and 2021, respectively. Sales of aftermarket products represented approximately 31%, 27%, and 31% of consolidated net sales for the years ended December 31, 2023, 2022 and 2021, respectively.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 25 OPERATING CASH FLOWS AND OTHER SUPPLEMENTAL FINANCIAL INFORMATION
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
(in millions) | 2023 | | 2022 | | 2021 |
OPERATING | | | | | |
Net earnings | $ | 102 | | | $ | 262 | | | $ | 153 | |
Adjustments to reconcile net earnings to net cash provided by operating activities: | | | | | |
Depreciation and tooling amortization | 143 | | | 142 | | | 175 | |
Intangible asset amortization | 28 | | | 28 | | | 29 | |
Restructuring expense, net of cash paid | — | | | 5 | | | 42 | |
Stock-based compensation expense | 10 | | | 11 | | | 11 | |
| | | | | |
| | | | | |
Asset impairments | — | | | 5 | | | 14 | |
| | | | | |
Deferred income tax provision (benefit) | 32 | | | 25 | | | (56) | |
| | | | | |
Other non-cash adjustments | (7) | | | 3 | | | 10 | |
Adjustments to reconcile net earnings to net cash provided by operating activities | 308 | | | 481 | | | 378 | |
| | | | | |
Changes in assets and liabilities, excluding foreign currency translation adjustments: | | | | | |
Receivables | 79 | | | (103) | | | 16 | |
Inventories | (4) | | | (60) | | | (84) | |
Prepayments and other current assets | (5) | | | 12 | | | (4) | |
Accounts payable and other current liabilities | (95) | | | 16 | | | (96) | |
Prepaid taxes and income taxes payable | — | | | 31 | | | 9 | |
Other assets and liabilities | (26) | | | (69) | | | (69) | |
Retirement plan contributions | (7) | | | (5) | | | (3) | |
Net cash provided by operating activities | $ | 250 | | | $ | 303 | | | $ | 147 | |
| | | | | |
SUPPLEMENTAL CASH FLOW INFORMATION | | | | | |
Cash paid during the year for: | | | | | |
Interest, net | $ | 26 | | | $ | 13 | | | $ | 14 | |
Income taxes, net of refunds | $ | 88 | | | $ | 51 | | | $ | 38 | |
Non-cash investing transactions: | | | | | |
Period end accounts payable related to property, plant and equipment purchases | $ | 48 | | | $ | 67 | | | $ | 44 | |
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 26 INTERIM FINANCIAL INFORMATION (UNAUDITED)
While preparing the Company’s consolidated financial statements for the year ended December 31, 2023, the Company identified a cross-currency intercompany loan that was contributed to equity as part of the legal entity step plan that covered the tax and legal transactions needed to complete the separation at the date of the Spin-Off. The loan was not appropriately accounted for as it remained recorded on the Company’s general ledger at the date of the Spin-Off. As a result, a foreign currency gain was improperly recorded through Selling, general and administrative expenses within the Statement of Operations for the three and nine months ended September 30, 2023. Further, there was an offsetting foreign currency cash pool liability intended to compensate for the remeasurement of the intercompany loan that remained outstanding at September 30, 2023. As the foreign currency loss related to this liability was related to the Spin-Off, it should have been recorded in Other operating expense (income), net, therefore it was misclassified within the Statement of Operations for the three and nine months ended September 30, 2023. The Company evaluated the errors and concluded that the errors were not material to its previously issued condensed consolidated financial statements. To correct the immaterial errors, the Company will revise the previously reported interim financial information in conjunction with the issuance of its quarterly report on Form 10-Q for the quarter ended September 30, 2024. The errors had no impact on the consolidated financial statements as of and for the fiscal year ended December 31, 2023.
The following table sets forth unaudited quarterly financial information for the years ended December 31, 2023 and 2022 reflecting the revision discussed above.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | 2023 | | 2022 |
(in millions, except per share amounts) | | Mar-31 | | Jun-30 | | Sep-30 | | Dec-31 | | Mar-31 | | Jun-30 | | Sep-30 | | Dec-31 |
Net sales | | $ | 835 | | | $ | 887 | | | $ | 896 | | | $ | 882 | | | $ | 842 | | | $ | 796 | | | $ | 859 | | | $ | 851 | |
| | | | | | | | | | | | | | | | |
Gross profit | | 172 | | | 189 | | | 177 | | | 186 | | | 174 | | | 158 | | | 201 | | | 188 | |
Selling, general and administrative expenses | | 99 | | | 103 | | | 104 | | | 107 | | | 100 | | | 101 | | | 100 | | | 106 | |
| | | | | | | | | | | | | | | | |
Other operating expense (income), net | | $ | 15 | | | $ | 30 | | | $ | 27 | | | $ | (2) | | | $ | 3 | | | $ | 8 | | | $ | (10) | | | $ | (5) | |
Operating income | | 58 | | | 56 | | | 46 | | | 81 | | | 71 | | | 49 | | | 111 | | | 87 | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Earnings before income taxes | | 58 | | | 56 | | | 30 | | | 62 | | | 78 | | | 54 | | | 121 | | | 94 | |
| | | | | | | | | | | | | | | | |
Net earnings (loss) | | $ | 35 | | | $ | 35 | | | $ | (1) | | | $ | 33 | | | $ | 57 | | | $ | 41 | | | $ | 89 | | | $ | 75 | |
| | | | | | | | | | | | | | | | |
Earnings (loss) per share - basic | | $ | 0.74 | | | $ | 0.74 | | | $ | (0.02) | | | $ | 0.71 | | | $ | 1.21 | | | $ | 0.87 | | | $ | 1.89 | | | $ | 1.60 | |
Earnings (loss) per share - diluted | | $ | 0.74 | | | $ | 0.74 | | | $ | (0.02) | | | $ | 0.70 | | | $ | 1.21 | | | $ | 0.87 | | | $ | 1.89 | | | $ | 1.60 | |
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
The tables below reflect the impact of the revisions on the unaudited quarterly financial information:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Condensed Consolidated Statements of Operations |
| | | | | | | | | | | |
| Three Months Ended September 30, 2023 | | Nine Months Ended September 30, 2023 |
(in millions, except per share amounts) | As Previously Reported | | Adjustment | | As Revised | | As Previously Reported | | Adjustment | | As Revised |
Selling, general and administrative expenses | $ | 104 | | | $ | — | | | $ | 104 | | | $ | 306 | | | $ | — | | | $ | 306 | |
Other operating expense (income), net | 15 | | | 12 | | | 27 | | | 60 | | | 12 | | | 72 | |
Operating income | 58 | | | (12) | | | 46 | | | 172 | | | (12) | | | 160 | |
Earnings before income taxes | 42 | | | (12) | | | 30 | | | 156 | | | (12) | | | 144 | |
Net earnings (loss) | 11 | | | (12) | | | (1) | | | 81 | | | (12) | | | 69 | |
Earnings (loss) per share - basic | $ | 0.24 | | | $ | (0.26) | | | $ | (0.02) | | | $ | 1.72 | | | $ | (0.26) | | | $ | 1.46 | |
Earnings (loss) per share - diluted | $ | 0.24 | | | $ | (0.26) | | | $ | (0.02) | | | $ | 1.72 | | | $ | (0.26) | | | $ | 1.46 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Condensed Consolidated Statements of Comprehensive (Loss) Income |
| | | | | | | | | | | |
| Three Months Ended September 30, 2023 | | Nine Months Ended September 30, 2023 |
(in millions) | As Previously Reported | | Adjustment | | As Revised | | As Previously Reported | | Adjustment | | As Revised |
Net earnings (loss) | $ | 11 | | | $ | (12) | | | $ | (1) | | | $ | 81 | | | $ | (12) | | | $ | 69 | |
Other comprehensive loss | | | | | | | | | | | |
Foreign currency translation adjustments | (58) | | | 12 | | | (46) | | | (28) | | | 12 | | | (16) | |
Total other comprehensive loss | (61) | | | 12 | | | (49) | | | (34) | | | 12 | | | (22) | |
| | | | | | | | | | | | | | | | | |
Condensed Consolidated Statement of Cash Flows |
| | | | | |
| Nine Months Ended September 30, 2023 |
(in millions) | As Previously Reported | | Adjustment | | As Revised |
Net earnings (loss) | $ | 81 | | | $ | (12) | | | $ | 69 | |
Other non-cash adjustments | (1) | | | 12 | | | 11 | |
| | | | | | | | | | | | | | | | | |
Condensed Consolidated Balance Sheet |
| | | | | |
| September 30, 2023 |
(in millions) | As Previously Reported | | Adjustment | | As Revised |
Retained Deficit | $ | (1) | | | $ | (12) | | | $ | (13) | |
Accumulated other comprehensive loss | (122) | | | 12 | | | (110) | |
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)